AXA/2025/FY/Earnings presentation: Difference between revisions
Appearance
< AXA
Content deleted Content added
PlumBot: publish from draft |
PlumBot: publish from draft |
||
| Line 24: | Line 24: | ||
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures === |
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures === |
||
* |
* '''Forward-looking statements''': This presentation contains statements that are predictions of or indicate future events, trends, plans, or objectives. They are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target', or conditional verbs like 'would' and 'could' <sup>p. 2</sup>. |
||
** A specific example is the statement regarding expected underlying earnings per share (UEPS) growth for 2026, which is provided as one-off guidance for the final year of the current strategic plan <sup>p. 2</sup>. |
|||
* Forward-looking statements are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target', 'would', and 'could' <sup>p. 2</sup>. |
|||
** These statements are based on management's current views and are subject to change. They involve known and unknown risks and uncertainties, many outside of AXA's control, which could cause actual results to differ materially <sup>p. 2</sup>. |
|||
* Statements regarding expected '''underlying earnings per share (UEPS) growth''' for 2026 are forward-looking, providing one-off guidance for the last year of the Group's current strategic plan <sup>p. 2</sup>. |
|||
* |
** For a description of important risk factors, refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 <sup>p. 2</sup>. |
||
** AXA disclaims any obligation to publicly update or revise these statements, except as required by law <sup>p. 2</sup>. |
|||
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties outside AXA's control <sup>p. 2</sup>. |
|||
* Factors could cause AXA's actual results to differ materially from those expressed or implied <sup>p. 2</sup>. |
|||
* '''Non-GAAP financial measures''': The presentation uses certain non-GAAP financial measures, or alternative performance measures (APMs), to analyze operating trends and financial performance <sup>p. 2</sup>. |
|||
* Each forward-looking statement speaks only at the date of this presentation <sup>p. 2</sup>. |
|||
** These measures may not be comparable to those used by other companies and should not be considered a substitute for IFRS financial statements <sup>p. 2</sup>. |
|||
* Refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of important factors, risks, and uncertainties <sup>p. 2</sup>. |
|||
** Examples of APMs include "Underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing", as defined by ESMA guidelines and the AMF's 2015 position statement <sup>p. 2</sup>. |
|||
* AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations <sup>p. 2</sup>. |
|||
* |
** Reconciliation of these APMs to IFRS measures can be found in AXA's 2025 Activity Report, with further details in the Glossary <sup>p. 2</sup>. |
||
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to similarly labeled measures used by other companies <sup>p. 2</sup>. |
|||
* '''Document availability''': AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com) <sup>p. 2</sup>. |
|||
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group's consolidated financial statements prepared in accordance with IFRS <sup>p. 2</sup>. |
|||
* '''Underlying earnings''', '''UEPS''' ('underlying earnings per share'), '''underlying return on equity''', '''combined ratio''', and '''debt gearing''' are APMs as defined in ESMA's guidelines and AMF's related position statement issued in 2015 <sup>p. 2</sup>. |
|||
* '''Financial statement status''': The consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to the completion of an audit by statutory auditors <sup>p. 2</sup>. |
|||
* AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' <sup>p. 2</sup>. |
|||
* For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report <sup>p. 2</sup>. |
|||
* |
* The presentation is titled "Full Year 2025 Earnings" <sup>p. 2</sup>. |
||
* AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors <sup>p. 2</sup>. |
|||
=== Table of contents === |
=== Table of contents === |
||
| Line 54: | Line 53: | ||
=== Full Year 2025 | Excellent performance === |
=== Full Year 2025 | Excellent performance === |
||
<div style="overflow-x:auto"> |
|||
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup> |
|||
{| class="wikitable" |
|||
* '''ROE''' 16% in FY25 <sup>p. 5</sup> |
|||
|+ FY25 key financial highlights <sup>p. 5</sup> |
|||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
* '''Solvency II ratio''' 224% in FY25 <sup>p. 5</sup> |
|||
! class="col-m" style="text-align:right" | Metric |
|||
* Delivering value for shareholders with +8% '''DPS''' growth and EUR 1.25bn annual share buyback <sup>p. 5</sup> |
|||
! class="col-m" style="text-align:right" | Value / Change |
|||
** '''Dividend''' proposed by AXA's Board of Directors on February 25, 2026, subject to approval by Shareholders' Annual General Meeting on April 30, 2026 <sup>p. 5</sup>. |
|||
|- |
|||
** '''Share buyback''' approved by AXA's Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions <sup>p. 5</sup>. |
|||
| style="text-align:left" | — |
|||
* Confident to deliver '''underlying EPS growth''' at the upper end of 6%-8% target range for 2026 <sup>p. 5</sup> |
|||
| class="col-m" style="text-align:right" | Revenues |
|||
| class="col-m" style="text-align:right" | +6% vs. FY24 |
|||
|- |
|||
| style="text-align:left" | — |
|||
| class="col-m" style="text-align:right" | Underlying EPS |
|||
| class="col-m" style="text-align:right" | +8% vs. FY24 |
|||
|- |
|||
| style="text-align:left" | — |
|||
| class="col-m" style="text-align:right" | ROE (FY25) |
|||
| class="col-m" style="text-align:right" | 16% |
|||
|- |
|||
| style="text-align:left" | — |
|||
| class="col-m" style="text-align:right" | Solvency II ratio (FY25) |
|||
| class="col-m" style="text-align:right" | 224% |
|||
|- |
|||
| style="text-align:left" | — |
|||
| class="col-m" style="text-align:right" | Dividend per Share (DPS) growth |
|||
| class="col-m" style="text-align:right" | +8% |
|||
|- |
|||
| style="text-align:left" | — |
|||
| class="col-m" style="text-align:right" | Annual share buyback |
|||
| class="col-m" style="text-align:right" | 1.25 |
|||
|} |
|||
</div> |
|||
* Confident to deliver underlying EPS growth at the upper end of the 6%-8% target range for 2026 <sup>p. 5</sup> |
|||
* ¹Dividend is based on the proposal by AXA's Board of Directors on February 25, 2026, and is subject to approval by the Shareholders' Annual General Meeting on April 30, 2026 <sup>p. 5</sup> |
|||
* ²Share buyback follows AXA's Board of Directors' approval on February 25, 2026, and is expected to commence as soon as reasonably practicable, subject to market conditions <sup>p. 5</sup> |
|||
=== Executing the plan on growth, margin and efficiency === |
=== Executing the plan on growth, margin and efficiency === |
||
| Line 77: | Line 103: | ||
|} |
|} |
||
</div> |
</div> |
||
* Underlying earnings +6% <sup>p. 6</sup> |
* '''Underlying earnings''' +6% <sup>p. 6</sup> |
||
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) <sup>p. 6</sup> |
* '''High organic growth''': +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) <sup>p. 6</sup> |
||
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup> |
* '''Record profitability''': Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup> |
||
* Scaling the business: Continued investments in growth and technology <sup>p. 6</sup> |
* '''Scaling the business''': Continued investments in growth and technology <sup>p. 6</sup> |
||
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup> |
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup> |
||
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup> |
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup> |
||
| Line 88: | Line 114: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ FY25 gross written premium split |
|+ FY25 gross written premium split <sup>p. 7</sup> |
||
! style="text-align:left" | Segment |
! style="text-align:left" | Segment |
||
! class="col-s" style="text-align:right" | Share |
! class="col-s" style="text-align:right" | Share |
||
| Line 108: | Line 134: | ||
|} |
|} |
||
</div> |
</div> |
||
* Secular trends fueling demand across businesses <sup>p. 7</sup> |
* '''Secular trends fueling demand across businesses''' <sup>p. 7</sup> |
||
* Protection gaps and emerging corporate risks (relevant for SME & Mid-market and Large & Specialty segments) <sup>p. 7</sup> |
** Protection gaps and emerging corporate risks (relevant for SME & Mid-market and Large & Specialty segments) <sup>p. 7</sup> |
||
* Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) <sup>p. 7</sup> |
** Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) <sup>p. 7</sup> |
||
* Our right to win <sup>p. 7</sup> |
* '''Our right to win''' <sup>p. 7</sup> |
||
* Leading brand & high customer NPS <sup>p. 7</sup> |
** Leading brand & high customer NPS <sup>p. 7</sup> |
||
* Strong and diversified distribution <sup>p. 7</sup> |
** Strong and diversified distribution <sup>p. 7</sup> |
||
* Technical expertise to price & underwrite risks <sup>p. 7</sup> |
** Technical expertise to price & underwrite risks <sup>p. 7</sup> |
||
* Scale offering cost advantage <sup>p. 7</sup> |
** Scale offering cost advantage <sup>p. 7</sup> |
||
=== Laying the foundation for the next plan === |
=== Laying the foundation for the next plan === |
||
| Line 134: | Line 160: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Key metrics by geography <sup>p. 10</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | GWP |
! class="col-s" style="text-align:right" | % of total GWP |
||
! class="col-s" style="text-align:right" | Gross written premiums |
|||
! class="col-s" style="text-align:right" | GWP change |
! class="col-s" style="text-align:right" | GWP change |
||
! class="col-s" style="text-align:right" | Underlying earnings |
! class="col-s" style="text-align:right" | Underlying earnings |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | UE change |
||
! class="col-s" style="text-align:right" | % of total GWP |
|||
|- |
|- |
||
| style="text-align:left" | France |
| style="text-align:left" | France |
||
| style="text-align:right" | 27% |
|||
| style="text-align:right" | 31 |
| style="text-align:right" | 31 |
||
| style="text-align:right" | +6% |
| style="text-align:right" | +6% |
||
| style="text-align:right" | 2.2 |
| style="text-align:right" | 2.2 |
||
| style="text-align:right" | +7% |
| style="text-align:right" | +7% |
||
| style="text-align:right" | 27% |
|||
|- |
|- |
||
| style="text-align:left" | Europe |
| style="text-align:left" | Europe |
||
| style="text-align:right" | 38% |
|||
| style="text-align:right" | 43 |
| style="text-align:right" | 43 |
||
| style="text-align:right" | +6% |
| style="text-align:right" | +6% |
||
| style="text-align:right" | 3.5 |
| style="text-align:right" | 3.5 |
||
| style="text-align:right" | +9% |
| style="text-align:right" | +9% |
||
| style="text-align:right" | 38% |
|||
|- |
|- |
||
| style="text-align:left" | AXA XL |
| style="text-align:left" | AXA XL |
||
| style="text-align:right" | 17% |
|||
| style="text-align:right" | 19 |
| style="text-align:right" | 19 |
||
| style="text-align:right" | +4% |
| style="text-align:right" | +4% |
||
| style="text-align:right" | 1.9 |
| style="text-align:right" | 1.9 |
||
| style="text-align:right" | +9% |
| style="text-align:right" | +9% |
||
| style="text-align:right" | 17% |
|||
|- |
|- |
||
| style="text-align:left" | Asia, Africa & EME-LATAM |
| style="text-align:left" | Asia, Africa & EME-LATAM |
||
| style="text-align:right" | 18% |
|||
| style="text-align:right" | 20 |
| style="text-align:right" | 20 |
||
| style="text-align:right" | +13% |
| style="text-align:right" | +13% |
||
| style="text-align:right" | 1.5 |
| style="text-align:right" | 1.5 |
||
| style="text-align:right" | +6% |
| style="text-align:right" | +6% |
||
| style="text-align:right" | 18% |
|||
|} |
|} |
||
</div> |
</div> |
||
* A checkmark icon is displayed next to each business segment's results <sup>p. 10</sup>. |
|||
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX |
|||
* |
* Footnotes: Changes for Gross written premiums are at constant scope and FX; changes for underlying earnings are at constant FX. The total GWP base for FY25 excludes AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>. |
||
=== P&C | Strong margins, confidence in sustaining growth === |
=== P&C | Strong margins, confidence in sustaining growth === |
||
| Line 178: | Line 204: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ GWP split |
|+ GWP split by segment <sup>p. 11</sup> |
||
! style="text-align:left" | Segment |
! style="text-align:left" | Segment |
||
! class="col-s" style="text-align:right" | Share |
! class="col-s" style="text-align:right" | Share |
||
| Line 192: | Line 218: | ||
|} |
|} |
||
</div> |
</div> |
||
* Underlying earnings +9% (FY25 vs. FY24 at constant FX) to EUR 5.9bn |
|||
* '''Underlying earnings''' +9% to EUR 5.9bn (FY25 vs. FY24 at constant FX) <sup>p. 11</sup>. |
|||
* Includes AXA XL Re premiums of EUR 2.6bn |
|||
* AXA XL (Large & Specialty) includes AXA XL Re premiums of EUR 2.6bn <sup>p. 11</sup>. |
|||
* '''2025 Strategic Focus''' |
|||
* '''Strategic priorities for 2025''' <sup>p. 11</sup>: |
|||
** '''Retail and SME & Mid-market''': Growing volumes while expanding margins |
|||
** ''' |
** '''Retail and SME & Mid-market''': Growing volumes while expanding margins <sup>p. 11</sup>. |
||
** '''AXA XL (Large & Specialty)''': Profitable growth with stable margins <sup>p. 11</sup>. |
|||
* '''Beyond 2025 Strategic Focus''' |
|||
* '''Strategic priorities beyond 2025''' <sup>p. 11</sup>: |
|||
** '''Retail and SME & Mid-market''': Investing to improve customer retention & expanding distribution footprint |
|||
** '''Retail and SME & Mid-market''': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>. |
|||
** '''AXA XL''' (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management |
|||
** '''AXA XL (Large & Specialty)''': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>. |
|||
* '''Additional Strategic Initiatives''' |
|||
* '''Additional drivers''' supporting growth include <sup>p. 11</sup>: |
|||
** Continued progress on efficiency |
|||
** Continued progress on efficiency <sup>p. 11</sup>. |
|||
** Higher investment income |
|||
** Higher investment income <sup>p. 11</sup>. |
|||
** Data & AI to further enhance customer experience & technical excellence |
|||
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>. |
|||
* (donut chart) '''GWP''' of EUR 58bn, with the following segment mix <sup>p. 11</sup>: |
|||
=== L&H | Good momentum, well positioned to capture growth opportunities === |
=== L&H | Good momentum, well positioned to capture growth opportunities === |
||
| Line 209: | Line 237: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ GWP split |
|+ GWP split by business type <sup>p. 12</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Business type |
||
! class="col-s" style="text-align:right" | Share |
! class="col-s" style="text-align:right" | Share |
||
|- |
|||
| style="text-align:left" | Short-term |
|||
| style="text-align:right" | 28% |
|||
|- |
|- |
||
| style="text-align:left" | Long-term |
| style="text-align:left" | Long-term |
||
| style="text-align:right" | |
| style="text-align:right" | 70% |
||
|- |
|||
| style="text-align:left" | Short-term |
|||
| style="text-align:right" | 30% |
|||
|} |
|} |
||
</div> |
</div> |
||
* Underlying earnings +7% (FY25 vs. FY24 at constant FX) to EUR 3.5bn |
|||
* '''Underlying earnings''' +7% to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>. |
|||
* '''2025 Strategic Focus''' |
|||
* '''Strategic priorities for 2025''': |
|||
** '''Long-term business''': Accelerating net flows in Savings at attractive margins |
|||
** ''' |
** '''Long-term business''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>. |
||
** '''Short-term business''': Growing technical results while absorbing the Mexico VAT impact <sup>p. 12</sup>. |
|||
* '''Beyond 2025 Strategic Focus''' |
|||
* '''Strategic priorities beyond 2025''': |
|||
** '''Long-term business''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers |
|||
** ''' |
** '''Long-term business''': Capturing savings & retirement opportunities and sourcing the best asset management products for customers <sup>p. 12</sup>. |
||
** '''Short-term business''': Capitalizing on demand for health & protection while further improving margins <sup>p. 12</sup>. |
|||
* '''Additional Strategic Initiatives''' |
|||
* '''Additional strategic initiatives''': |
|||
** Focus on cost reduction |
|||
** Focus on cost reduction <sup>p. 12</sup>. |
|||
** Increasing penetration of Protection riders in Savings offerings |
|||
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>. |
|||
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health |
|||
** Leveraging AI to reduce claims leakage and improve customer outcomes in Health <sup>p. 12</sup>. |
|||
* (donut) '''GWP''' of EUR 57bn, split between Long-term (70%) and Short-term (30%) business <sup>p. 12</sup>. |
|||
== FY25 Financial Performance == |
== FY25 Financial Performance == |
||
| Line 241: | Line 271: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ GWP & other revenues |
|+ GWP & other revenues breakdown, FY25 vs FY24 <sup>p. 14</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Change |
|||
! class="col-s" style="text-align:right" | Pricing effect |
|||
! class="col-s" style="text-align:right" | Volume effect |
|||
|- |
|- |
||
| style="text-align:left" | Commercial lines |
| style="text-align:left" | Commercial lines |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 35.8 |
| style="text-align:right" | 35.8 |
||
| style="text-align:right" | 35.8 |
|||
|- |
|||
| style="text-align:left" | AXA XL Reinsurance |
|||
| style="text-align:right" | 2.6 |
|||
| style="text-align:right" | 2.6 |
|||
|- |
|||
| style="text-align:left" | Retail lines |
|||
| style="text-align:right" | 18.1 |
|||
| style="text-align:right" | 19.7 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 56.5 |
|||
| style="text-align:right; font-weight:bold" | 58.0 |
|||
|} |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
|+ Change at constant scope and FX <sup>p. 14</sup> |
|||
! style="text-align:left" | Segment |
|||
! class="col-s" style="text-align:right" | Change |
|||
! class="col-s" style="text-align:right" | Pricing |
|||
! class="col-s" style="text-align:right" | Volume |
|||
|- |
|||
| style="text-align:left" | Commercial lines |
|||
| style="text-align:right" | +4% |
| style="text-align:right" | +4% |
||
| style="text-align:right" | +2% |
| style="text-align:right" | +2% |
||
| Line 278: | Line 287: | ||
|- |
|- |
||
| style="text-align:left" | AXA XL Reinsurance |
| style="text-align:left" | AXA XL Reinsurance |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2.6 |
|||
| style="text-align:right" | +8% |
| style="text-align:right" | +8% |
||
| style="text-align:right" | +0.3% |
| style="text-align:right" | +0.3% |
||
| Line 283: | Line 294: | ||
|- |
|- |
||
| style="text-align:left" | Retail lines |
| style="text-align:left" | Retail lines |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 19.7 |
|||
| style="text-align:right" | +7% |
| style="text-align:right" | +7% |
||
| style="text-align:right" | +5% |
| style="text-align:right" | +5% |
||
| style="text-align:right" | +2% |
| style="text-align:right" | +2% |
||
|- |
|||
| style="text-align:left" | '''Total''' |
|||
| style="text-align:right" | '''56.5''' |
|||
| style="text-align:right" | '''58.0''' |
|||
| style="text-align:right" | '''+5%''' |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
* Continued pricing momentum and volume growth in Mid-market and SME |
* Commercial lines: Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>. |
||
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance |
* Commercial lines: Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>. |
||
* Growth supported by alternative capital |
* AXA XL Reinsurance: Growth supported by alternative capital <sup>p. 14</sup>. |
||
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) |
* Retail lines: Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>. |
||
* |
* All changes are at constant scope and FX. "Pricing" refers to price effect. "Volume" includes exposure adjustments and mix & other effects <sup>p. 14</sup>. |
||
=== P&C | Delivering further margin expansion while enhancing reserve prudence === |
=== P&C | Delivering further margin expansion while enhancing reserve prudence === |
||
| Line 298: | Line 318: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Combined ratio, FY24 vs FY25 <sup>p. 15</sup> |
|+ Combined ratio components, FY24 vs FY25 <sup>p. 15</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Ratio (%) |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
| Line 323: | Line 343: | ||
| style="text-align:right" | -3.5% |
| style="text-align:right" | -3.5% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Combined ratio''' |
||
| style="text-align:right |
| style="text-align:right" | '''91.0%''' |
||
| style="text-align:right |
| style="text-align:right" | '''90.6%''' |
||
|} |
|} |
||
</div> |
</div> |
||
* |
* A better '''undiscounted current year loss ratio''' (excluding Nat Cat) was driven by: <sup>p. 15</sup> |
||
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment |
** Margin expansion in Commercial lines SME & mid-market business and Personal lines, reflecting a favorable pricing environment <sup>p. 15</sup>. |
||
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management |
** Stable AXA XL Insurance margins at attractive levels, reflecting disciplined cycle management <sup>p. 15</sup>. |
||
* |
* The '''expense ratio''' improved, reflecting the impact of efficiency measures, while the company continued to invest in growth initiatives and technology <sup>p. 15</sup>. |
||
* Nat Cat charges below normalized load |
* '''Nat Cat charges''' were below the normalized load <sup>p. 15</sup>. |
||
* |
* There was a '''lower reliance''' on prior year reserve development <sup>p. 15</sup>. |
||
* |
* The company is taking advantage of a good year to '''enhance reserve prudence''' <sup>p. 15</sup>. |
||
=== P&C | Earnings growth from higher underwriting and financial result === |
=== P&C | Earnings growth from higher underwriting and financial result === |
||
| Line 340: | Line 360: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Underlying earnings |
|+ Underlying earnings bridge, FY24 to FY25 <sup>p. 16</sup> |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | Underlying |
! class="col-s" style="text-align:right" | Underlying earnings |
||
|- |
|- |
||
| style="text-align:left" | FY24 |
| style="text-align:left" | FY24 |
||
| Line 369: | Line 389: | ||
|} |
|} |
||
</div> |
</div> |
||
* Underlying Earnings +9% (constant FX) |
|||
* The above two components form the "Underwriting result," which includes expenses <sup>p. 16</sup>. |
|||
* Better underwriting result from strong volume growth and improved all-year combined ratio while enhancing reserve prudence |
|||
* The above two components form the "Financial result" <sup>p. 16</sup>. |
|||
* Increase in investment income reflecting higher volumes and better reinvestment yields on fixed income assets |
|||
* Better underwriting result from strong volume growth and an improved all-year combined ratio, while enhancing reserve prudence <sup>p. 16</sup>. |
|||
* Higher unwind of discount of claims reserves, in line with guidance |
|||
* Increase in investment income reflects higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>. |
|||
* Unfavorable forex impact notably due to USD depreciation vs. EUR |
|||
* Higher unwind of discount of claims reserves was in line with guidance <sup>p. 16</sup>. |
|||
* An unfavorable forex impact was recorded, notably due to USD depreciation vs. EUR <sup>p. 16</sup>. |
|||
* (waterfall) '''Underlying earnings''' bridge FY24 to FY25 (in EUR million, at constant FX): EUR 5,510m → EUR 5,872m (+9%) <sup>p. 16</sup> |
|||
=== Life & Health | Strong growth in premiums, positive net flows === |
=== Life & Health | Strong growth in premiums, positive net flows === |
||
* All figures are in EUR billion. All changes are at constant scope and FX <sup>p. 17</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ GWP & other revenues |
|+ Life GWP & other revenues, FY24 vs FY25 <sup>p. 17</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change |
||
|- |
|||
| style="text-align:left" | '''Life GWP & Other Revenues''' |
|||
| style="text-align:right" | 34.5 |
|||
| style="text-align:right" | 37.5 |
|||
| style="text-align:right" | +9% |
|||
|- |
|- |
||
| style="text-align:left" | Protection |
| style="text-align:left" | Protection |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 17.3 |
| style="text-align:right" | 17.3 |
||
| style="text-align:right" | 19.0 |
|||
| style="text-align:right" | +11% |
| style="text-align:right" | +11% |
||
|- |
|- |
||
| style="text-align:left" | Unit-linked |
| style="text-align:left" | Unit-linked |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 9.3 |
| style="text-align:right" | 9.3 |
||
| style="text-align:right" | 10.5 |
|||
| style="text-align:right" | +13% |
| style="text-align:right" | +13% |
||
|- |
|- |
||
| style="text-align:left" | Capital light G/A |
| style="text-align:left" | Capital light G/A |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 9.0 |
||
| style="text-align:right" | +7% |
| style="text-align:right" | +7% |
||
|- |
|- |
||
| style="text-align:left" | Traditional G/A |
| style="text-align:left" | Traditional G/A |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 1.9 |
| style="text-align:right" | 1.9 |
||
| style="text-align:right" | -7% |
| style="text-align:right" | -7% |
||
|- |
|- |
||
| style="text-align:left" | ''' |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''34.5''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''37.5''' |
||
| style="text-align:right" | + |
| style="text-align:right" | '''+9%''' |
||
|} |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
|+ Health GWP & other revenues, FY24 vs FY25 <sup>p. 17</sup> |
|||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Change |
|||
|- |
|- |
||
| style="text-align:left" | Individual |
| style="text-align:left" | Individual |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 10.5 |
| style="text-align:right" | 10.5 |
||
| style="text-align:right" | 11.1 |
|||
| style="text-align:right" | +6% |
| style="text-align:right" | +6% |
||
|- |
|- |
||
| style="text-align:left" | Group |
| style="text-align:left" | Group |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 8.5 |
||
| style="text-align:right" | +4% |
| style="text-align:right" | +4% |
||
|- |
|||
| style="text-align:left" | '''Total''' |
|||
| style="text-align:right" | '''17.5''' |
|||
| style="text-align:right" | '''19.0''' |
|||
| style="text-align:right" | '''+5%''' |
|||
|} |
|} |
||
</div> |
</div> |
||
| Line 429: | Line 464: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Net flows by segment <sup>p. 17</sup> |
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|- |
||
| style="text-align:left" | Protection |
| style="text-align:left" | Protection |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | +4.9 |
| style="text-align:right" | +4.9 |
||
|- |
|- |
||
| style="text-align:left" | Health |
| style="text-align:left" | Health |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | +2.7 |
| style="text-align:right" | +2.7 |
||
|- |
|- |
||
| style="text-align:left" | Unit-Linked |
| style="text-align:left" | Unit-Linked |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | +1.5 |
| style="text-align:right" | +1.5 |
||
|- |
|- |
||
| style="text-align:left" | Capital light G/A |
| style="text-align:left" | Capital light G/A |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | +1.2 |
| style="text-align:right" | +1.2 |
||
|- |
|- |
||
| style="text-align:left" | Traditional G/A |
| style="text-align:left" | Traditional G/A |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | -5.0 |
| style="text-align:right" | -5.0 |
||
|- |
|||
| style="text-align:left" | '''Total''' |
|||
| style="text-align:right" | '''+1.5''' |
|||
| style="text-align:right" | '''+5.4''' |
|||
|} |
|} |
||
</div> |
</div> |
||
* '''FY25 Employee Benefits''' GWP and other revenues were EUR 12.9bn (+4% vs. FY24), including both short-term and long-term benefits <sup>p. 17</sup>. |
|||
* Net flows: EUR +5.4bn vs. EUR +1.5bn in FY24 |
|||
* Employee Benefits (short-term and long-term) FY25: EUR 12.9bn (+4% vs. FY24) |
|||
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting === |
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting === |
||
* All figures are in EUR billion and changes are at constant scope and FX. <sup>p. 18</sup> |
|||
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes. <sup>p. 18</sup> |
|||
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits. <sup>p. 18</sup> |
|||
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France. <sup>p. 18</sup> |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Key value metrics, FY24 vs FY25 <sup>p. 18</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 464: | Line 512: | ||
|- |
|- |
||
| style="text-align:left" | '''PVEP''' |
| style="text-align:left" | '''PVEP''' |
||
| style="text-align:right" | 50.9 |
| style="text-align:right" | '''50.9''' |
||
| style="text-align:right" | 49.4 |
| style="text-align:right" | '''49.4''' |
||
| style="text-align:right" | -2% |
| style="text-align:right" | '''-2%''' |
||
|- |
|- |
||
| style="text-align:left" | Protection & Health |
| style="text-align:left" | Protection & Health |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 31.4 |
| style="text-align:right" | 31.4 |
||
| style="text-align:right" | -4% |
| style="text-align:right" | -4% |
||
|- |
|- |
||
| style="text-align:left" | Unit-Linked |
| style="text-align:left" | Unit-Linked |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 8.5 |
| style="text-align:right" | 8.5 |
||
| style="text-align:right" | +18% |
| style="text-align:right" | +18% |
||
|- |
|- |
||
| style="text-align:left" | Capital-light G/A |
| style="text-align:left" | Capital-light G/A |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 7.8 |
| style="text-align:right" | 7.8 |
||
| style="text-align:right" | -10% |
| style="text-align:right" | -10% |
||
|- |
|- |
||
| style="text-align:left" | Traditional G/A |
| style="text-align:left" | Traditional G/A |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 1.7 |
| style="text-align:right" | 1.7 |
||
| style="text-align:right" | -10% |
| style="text-align:right" | -10% |
||
|} |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup> |
|||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|- |
||
| style="text-align:left" | NB CSM (pre-tax) |
| style="text-align:left" | '''NB CSM (pre-tax)''' |
||
| style="text-align:right" | 2.2 |
| style="text-align:right" | '''2.2''' |
||
| style="text-align:right" | 2.2 |
| style="text-align:right" | '''2.2''' |
||
| style="text-align:right" | '''+3%''' |
|||
|- |
|- |
||
| style="text-align:left" | NBV (post-tax) |
| style="text-align:left" | '''NBV (post-tax)''' |
||
| style="text-align:right" | 2.3 |
| style="text-align:right" | '''2.3''' |
||
| style="text-align:right" | 2.2 |
| style="text-align:right" | '''2.2''' |
||
| style="text-align:right" | '''stable''' |
|||
|- |
|- |
||
| style="text-align:left" | NBV margin |
| style="text-align:left" | NBV margin |
||
| style="text-align:right" | 4.4% |
| style="text-align:right" | 4.4% |
||
| style="text-align:right" | 4.5% |
| style="text-align:right" | 4.5% |
||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes |
|||
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits |
|||
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France |
|||
* (bar) '''NB CSM''' (pre-tax) +3% (constant scope and FX) <sup>p. 18</sup> |
|||
=== Life & Health | Growth in new business driving Normalized CSM growth === |
=== Life & Health | Growth in new business driving Normalized CSM growth === |
||
| Line 520: | Line 557: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Contractual Service Margin rollforward <sup>p. 19</sup> |
|+ Contractual Service Margin (CSM) rollforward, FY24 to FY25 <sup>p. 19</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | CSM |
||
! class="col-s" style="text-align:right" | Life CSM |
|||
! class="col-s" style="text-align:right" | Health CSM |
|||
|- |
|- |
||
| style="text-align:left" | FY24 |
| style="text-align:left" | '''FY24''' |
||
| style="text-align:right" | 33.6 |
| style="text-align:right" | '''33.6''' |
||
| style="text-align:right" | '''25.8''' |
|||
| style="text-align:right" | '''7.7''' |
|||
|- |
|- |
||
| style="text-align:left" | New business CSM |
| style="text-align:left" | New business CSM |
||
| style="text-align:right" | +2.2 |
| style="text-align:right" | +2.2 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Underlying return on in-force |
| style="text-align:left" | Underlying return on in-force |
||
| style="text-align:right" | +1.3 |
| style="text-align:right" | +1.3 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | CSM release |
| style="text-align:left" | CSM release |
||
| style="text-align:right" | -3.0 |
| style="text-align:right" | -3.0 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Economic variance |
| style="text-align:left" | Economic variance |
||
| style="text-align:right" | +0.6 |
| style="text-align:right" | +0.6 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Operating variance |
| style="text-align:left" | Operating variance |
||
| style="text-align:right" | -0.3 |
| style="text-align:right" | -0.3 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Affiliates, FX & other |
| style="text-align:left" | Affiliates, FX & other |
||
| style="text-align:right" | -1.4 |
| style="text-align:right" | -1.4 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | FY25 |
| style="text-align:left" | '''FY25''' |
||
| style="text-align:right" | 33.0 |
| style="text-align:right" | '''33.0''' |
||
| style="text-align:right" | '''25.4''' |
|||
| style="text-align:right" | '''7.6''' |
|||
|} |
|} |
||
</div> |
</div> |
||
* '''Normalized CSM''' increased by +2% at constant scope and FX; CSM release growth reflects better margins, while new business CSM growth was impacted by higher rates <sup>p. 19</sup>. |
|||
* '''Economic variance''' reflects tightening government spreads and positive equity market returns <sup>p. 19</sup>. |
|||
* '''Operating variance''' was driven by better margins and net flows, which were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>. |
|||
* '''FX impact''' was mainly from JPY and HKD depreciation <sup>p. 19</sup>. |
|||
=== Life & Health | Strong momentum in both short-term and long-term business === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Underlying earnings walk by component, FY24 to FY25 <sup>p. 20</sup> |
||
! style="text-align:left" | EUR |
! style="text-align:left" | EUR million unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Short-term technical margin |
||
| style="text-align:right" | |
| style="text-align:right" | 415 |
||
| style="text-align:right" | |
| style="text-align:right" | 479 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Long-term result incl. CSM release |
||
| style="text-align:right" | |
| style="text-align:right" | 2,680 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,804 |
||
|- |
|||
| style="text-align:left" | Financial result |
|||
| style="text-align:right" | 975 |
|||
| style="text-align:right" | 946 |
|||
|- |
|||
| style="text-align:left" | Tax & others |
|||
| style="text-align:right" | -748 |
|||
| style="text-align:right" | -728 |
|||
|- |
|||
| style="text-align:left" | '''Total Underlying earnings''' |
|||
| style="text-align:right" | '''3,323''' |
|||
| style="text-align:right" | '''3,501''' |
|||
|} |
|} |
||
</div> |
</div> |
||
* Normalized CSM up by +2% (constant scope and FX), with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates |
|||
* Economic variance reflecting government spreads tightening and positive equity market returns |
|||
* Operating variance driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland |
|||
* FX impact mainly from JPY and HKD depreciation |
|||
=== Life & Health | Strong momentum in both short-term and long-term business === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 600: | Line 666: | ||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
|||
* '''Underlying Earnings''' +7% (constant FX) <sup>p. 20</sup> |
|||
{| class="wikitable fintable" |
|||
* Strong '''short-term technical margin''' reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup> |
|||
|+ Underlying earnings by segment, FY24 vs FY25 <sup>p. 20</sup> |
|||
* Higher '''long-term results''' from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins <sup>p. 20</sup> |
|||
! style="text-align:left" | EUR billion |
|||
* '''Underlying Earnings by segment''': |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
** '''Life''': FY24 EUR 2.6bn, FY25 EUR 2.7bn (+4% vs. FY24) <sup>p. 20</sup> |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
** '''Health''': FY24 EUR 0.7bn, FY25 EUR 0.8bn (+17% vs. FY24) <sup>p. 20</sup> |
|||
! class="col-s" style="text-align:right" | Change vs. FY24 |
|||
* '''Short-term technical margin''': EUR 479m <sup>p. 20</sup> |
|||
|- |
|||
* '''Long-term result incl. CSM release''': EUR 2,804m <sup>p. 20</sup> |
|||
| style="text-align:left" | Life |
|||
* '''Financial result''': EUR 946m <sup>p. 20</sup> |
|||
| style="text-align:right" | 2.6 |
|||
* '''Tax & others''': -EUR 728m <sup>p. 20</sup> |
|||
| style="text-align:right" | 2.7 |
|||
| style="text-align:right" | +4% |
|||
|- |
|||
| style="text-align:left" | Health |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 0.8 |
|||
| style="text-align:right" | +17% |
|||
|} |
|||
</div> |
|||
* Strong '''short-term technical margin''' reflects underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup>. |
|||
* Higher '''long-term results''' from an increase in CSM release (+8%), reflecting growth in the reserve base, including from favorable equity market performance and better margins <sup>p. 20</sup>. |
|||
* (waterfall) '''Underlying earnings''' +7% at constant FX, from EUR 3,323m in FY24 to EUR 3,501m in FY25 <sup>p. 20</sup>. |
|||
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM === |
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM === |
||
| Line 615: | Line 693: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Group earnings summary, FY24 vs FY25 <sup>p. 21</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 624: | Line 702: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Property & Casualty |
| style="text-align:left" | Property & Casualty |
||
| Line 644: | Line 722: | ||
| style="text-align:right" | -1.2 |
| style="text-align:right" | -1.2 |
||
| style="text-align:right" | -1.2 |
| style="text-align:right" | -1.2 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total underlying earnings''' |
||
| style="text-align:right" | 8.1 |
| style="text-align:right" | '''8.1''' |
||
| style="text-align:right" | 8.4 |
| style="text-align:right" | '''8.4''' |
||
| style="text-align:right" | +6% |
| style="text-align:right" | '''+6%''' |
||
|- |
|- |
||
| style="text-align:left" | '''Net income''' |
| style="text-align:left" | '''Net income reconciliation''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | +26% |
|||
|- |
|- |
||
| style="text-align:left" | Non-financial flows |
| style="text-align:left" | Non-financial flows |
||
| style="text-align:right" | -0.5 |
| style="text-align:right" | -0.5 |
||
| style="text-align:right" | 2.1 |
| style="text-align:right" | +2.1 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; padding-left:1.5em" | o/w capital gains from AXA IM disposal |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | 2.2 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Financial flows (incl. RCG) |
| style="text-align:left" | Financial flows (incl. RCG) |
||
| style="text-align:right" | 0.3 |
| style="text-align:right" | +0.3 |
||
| style="text-align:right" | -0.7 |
| style="text-align:right" | -0.7 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total net income''' |
||
| style="text-align:right" | 7.9 |
| style="text-align:right" | '''7.9''' |
||
| style="text-align:right" | 9.8 |
| style="text-align:right" | '''9.8''' |
||
| style="text-align:right" | +26% |
| style="text-align:right" | '''+26%''' |
||
|} |
|} |
||
</div> |
</div> |
||
* Of which capital gains from AXA IM disposal: FY25 EUR +2.2bn <sup>p. 21</sup> |
|||
* Commentary on '''underlying earnings''': |
|||
** Driven by strong performance from insurance businesses <sup>p. 21</sup>. |
|||
** Stable holding cost is expected to remain at the current level in 2026 <sup>p. 21</sup>. |
|||
* Commentary on '''net income''': |
|||
** Higher net income mainly reflects higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>. |
|||
** Lower financial flows reflect unfavorable forex impact <sup>p. 21</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Underlying earnings per share |
|+ Underlying earnings per share, FY24 vs FY25 <sup>p. 21</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Euro |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Change |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Underlying earnings per share |
||
| style="text-align:right" | 3.59 |
| style="text-align:right" | 3.59 |
||
|- |
|||
| style="text-align:left" | Earnings growth |
|||
| style="text-align:right" | +6% |
|||
|- |
|||
| style="text-align:left" | Capital management |
|||
| style="text-align:right" | +3% |
|||
|- |
|||
| style="text-align:left" | Forex |
|||
| style="text-align:right" | -2% |
|||
|- |
|||
| style="text-align:left" | FY25 |
|||
| style="text-align:right" | 3.86 |
| style="text-align:right" | 3.86 |
||
| style="text-align:right" | +8% |
|||
|} |
|} |
||
</div> |
</div> |
||
* Drivers of change: |
|||
* |
** +6% from earnings growth <sup>p. 21</sup> |
||
** +3% from capital management <sup>p. 21</sup> |
|||
* '''Underlying earnings''': Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup> |
|||
* |
** -2% from forex, which includes -1% from temporary earnings dilution from the AXA IM sale due to the timing of the anti-dilutive share buyback <sup>p. 21</sup> |
||
* Change for underlying earnings and net income is at constant FX; change for underlying earnings per share is on a reported basis <sup>p. 21</sup>. |
|||
* '''Net income''': Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup> |
|||
* Change at constant FX for underlying earnings and net income <sup>p. 21</sup> |
|||
* Change on reported basis for underlying earnings per share <sup>p. 21</sup> |
|||
* (bar) '''Underlying earnings per share''': EUR 3.59 (FY24) → EUR 3.86 (FY25) (+8%) <sup>p. 21</sup> |
|||
* including -1% from temporary earnings dilution from AXA IM sale due to the timing of anti-dilutive share buyback <sup>p. 21</sup> |
|||
=== Shareholders' Equity === |
=== Shareholders' Equity === |
||
| Line 714: | Line 782: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Shareholders' equity and |
|+ Shareholders' equity and key ratios <sup>p. 22</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | HY25 |
! class="col-s" style="text-align:right" | HY25 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
|- |
|||
| style="text-align:left" | Shareholders' equity (Group share) |
|||
| style="text-align:right" | 49.9 |
|||
| style="text-align:right" | 45.5 |
|||
| style="text-align:right" | 47.2 |
|||
|- |
|- |
||
| style="text-align:left" | SHE (excl. OCI) |
| style="text-align:left" | SHE (excl. OCI) |
||
| Line 749: | Line 822: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Shareholders' equity reconciliation |
|+ Shareholders' equity reconciliation <sup>p. 22</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 to FY25 |
! class="col-s" style="text-align:right" | FY24 to FY25 |
||
! class="col-s" style="text-align:right" | HY25 to FY25 |
! class="col-s" style="text-align:right" | HY25 to FY25 |
||
|- |
|- |
||
| style="text-align:left" | Opening Shareholders' equity |
| style="text-align:left" | '''Opening Shareholders' equity''' |
||
| style="text-align:right" | 49.9 |
| style="text-align:right" | '''49.9''' |
||
| style="text-align:right" | 45.5 |
| style="text-align:right" | '''45.5''' |
||
|- |
|- |
||
| style="text-align:left" | Change in Net OCI |
| style="text-align:left" | Change in Net OCI |
||
| style="text-align:right" | 1.3 |
| style="text-align:right" | +1.3 |
||
| style="text-align:right" | 0.4 |
| style="text-align:right" | +0.4 |
||
|- |
|- |
||
| style="text-align:left" | Net income for the period |
| style="text-align:left" | Net income for the period |
||
| style="text-align:right" | 9.8 |
| style="text-align:right" | +9.8 |
||
| style="text-align:right" | 5.9 |
| style="text-align:right" | +5.9 |
||
|- |
|- |
||
| style="text-align:left" | Dividend |
| style="text-align:left" | Dividend |
||
| style="text-align:right" | -4.6 |
| style="text-align:right" | -4.6 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Annual share buyback |
| style="text-align:left" | Annual share buyback |
||
| style="text-align:right" | -1.2 |
| style="text-align:right" | -1.2 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Anti-dilutive share buyback |
| style="text-align:left" | Anti-dilutive share buyback |
||
| style="text-align:right" | -3.5 |
| style="text-align:right" | -3.5 |
||
| style="text-align:right" | -3.5 |
| style="text-align:right" | -3.5 |
||
|- |
|- |
||
| style="text-align:left" | Undated subordinated debt |
| style="text-align:left" | Undated subordinated debt |
||
| style="text-align:right" | -0.3 |
| style="text-align:right" | -0.3 |
||
| style="text-align:right" | -1.2 |
| style="text-align:right" | -1.2 |
||
| Line 788: | Line 861: | ||
| style="text-align:left" | Other |
| style="text-align:left" | Other |
||
| style="text-align:right" | -0.6 |
| style="text-align:right" | -0.6 |
||
| style="text-align:right" | 0.3 |
| style="text-align:right" | +0.3 |
||
|- |
|- |
||
| style="text-align:left" | Closing Shareholders' equity |
| style="text-align:left" | '''Closing Shareholders' equity''' |
||
| style="text-align:right" | 47.2 |
| style="text-align:right" | '''47.2''' |
||
| style="text-align:right" | 47.2 |
| style="text-align:right" | '''47.2''' |
||
|} |
|} |
||
</div> |
</div> |
||
* Footnote: Shareholders' equity is Group share <sup>p. 22</sup>. |
|||
* |
* All figures are in EUR billion <sup>p. 22</sup>. |
||
* '''Shareholders' equity reconciliation''' (in Euro billion) <sup>p. 22</sup> |
|||
=== Higher organic cash remittance and robust cash position at Holding === |
=== Higher organic cash remittance and robust cash position at Holding === |
||
| Line 803: | Line 875: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Net |
|+ Net cash remittance and holding cash position walk, FY24-FY25 <sup>p. 23</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Ordinary remittance |
||
| style="text-align:right" | 7. |
| style="text-align:right" | 7.1 |
||
| style="text-align:right" | 7.5 |
| style="text-align:right" | 7.5 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Proceeds from in-force treaties |
||
| style="text-align:right" | 0.6 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | '''Total net cash remittance''' |
|||
| style="text-align:right" | '''7.7''' |
|||
| style="text-align:right" | '''7.5''' |
|||
|- |
|||
| style="text-align:left" | Remittance ratio (%) |
|||
| style="text-align:right" | 82% |
| style="text-align:right" | 82% |
||
| style="text-align:right" | 82% |
| style="text-align:right" | 82% |
||
|} |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | EUR billion |
|||
! class="col-s" style="text-align:right" | Holding cash position walk |
|||
|- |
|- |
||
| style="text-align:left" | Cash position |
| style="text-align:left" | '''FY24 Cash position''' |
||
| style="text-align:right" | 4.0 |
| style="text-align:right" | '''4.0''' |
||
|- |
|||
| style="text-align:right" | 5.6 |
|||
| style="text-align:left" | Net cash remittance from subsidiaries |
|||
| style="text-align:right" | +7.5 |
|||
|- |
|||
| style="text-align:left" | Dividend |
|||
| style="text-align:right" | -4.6 |
|||
|- |
|||
| style="text-align:left" | Annual share buyback |
|||
| style="text-align:right" | -1.2 |
|||
|- |
|||
| style="text-align:left" | Anti-dilutive share buyback |
|||
| style="text-align:right" | -3.5 |
|||
|- |
|||
| style="text-align:left" | Holding costs and interest expenses |
|||
| style="text-align:right" | -1.3 |
|||
|- |
|||
| style="text-align:left" | Change in net debt |
|||
| style="text-align:right" | +1.6 |
|||
|- |
|||
| style="text-align:left" | M&A and other |
|||
| style="text-align:right" | +3.1 |
|||
|- |
|||
| style="text-align:left" | '''FY25 Cash position''' |
|||
| style="text-align:right" | '''5.6''' |
|||
|} |
|} |
||
</div> |
</div> |
||
* |
* The EUR 0.6bn proceeds are related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe. |
||
* |
* Remittance ratio is based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25. |
||
* All figures in EUR billion <sup>p. 23</sup>. |
|||
* Dividend: -EUR 4.6bn |
|||
* Annual share buyback: -EUR 1.2bn |
|||
* Anti-dilutive share buyback following the sale of AXA IM: -EUR 3.5bn |
|||
* Holding costs and interest expenses: -EUR 1.3bn |
|||
* Change in net debt: +EUR 1.6bn |
|||
* M&A and other: +EUR 3.1bn |
|||
* 1. Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25 |
|||
* 2. EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe |
|||
=== Solvency II at 224% === |
=== Solvency II at 224% === |
||
| Line 837: | Line 940: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Solvency II walk |
|+ Solvency II walk from FY24 to FY25 <sup>p. 24</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | Solvency II ratio (pts) |
|||
! class="col-s" style="text-align:right" | Eligible Own Funds (EOF) |
! class="col-s" style="text-align:right" | Eligible Own Funds (EOF) |
||
! class="col-s" style="text-align:right" | Solvency Capital Requirement (SCR) |
! class="col-s" style="text-align:right" | Solvency Capital Requirement (SCR) |
||
! class="col-s" style="text-align:right" | Solvency II ratio (pts) |
|||
|- |
|- |
||
| style="text-align:left" | FY24 |
| style="text-align:left" | '''FY24''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''216''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''55.9''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''25.9''' |
||
|- |
|- |
||
| style="text-align:left" | Regulatory & model changes |
| style="text-align:left" | Regulatory & model changes |
||
| style="text-align:right" | +0 |
|||
| style="text-align:right" | +0.2 |
| style="text-align:right" | +0.2 |
||
| style="text-align:right" | 0.0 |
| style="text-align:right" | 0.0 |
||
| style="text-align:right" | +0 |
|||
|- |
|- |
||
| style="text-align:left" | Normalized capital generation |
| style="text-align:left" | Normalized capital generation |
||
| style="text-align:right" | +28 |
|||
| style="text-align:right" | +8.8 |
| style="text-align:right" | +8.8 |
||
| style="text-align:right" | +0.6 |
| style="text-align:right" | +0.6 |
||
| style="text-align:right" | +28 |
|||
|- |
|- |
||
| style="text-align:left" | Operating variance |
| style="text-align:left" | Operating variance |
||
| style="text-align:right" | -1 |
|||
| style="text-align:right" | -0.4 |
| style="text-align:right" | -0.4 |
||
| style="text-align:right" | 0.0 |
| style="text-align:right" | 0.0 |
||
| style="text-align:right" | -1 |
|||
|- |
|- |
||
| style="text-align:left" | Economic & FX |
| style="text-align:left" | Economic variance & FX |
||
| style="text-align:right" | +4 |
|||
| style="text-align:right" | -2.1 |
| style="text-align:right" | -2.1 |
||
| style="text-align:right" | -1.2 |
| style="text-align:right" | -1.2 |
||
| style="text-align:right" | +4 |
|||
|- |
|- |
||
| style="text-align:left" | Dividend & annual share buyback |
| style="text-align:left" | Dividend & annual share buyback |
||
| style="text-align:right" | -24 |
|||
| style="text-align:right" | -6.0 |
| style="text-align:right" | -6.0 |
||
| style="text-align:right" | 0.0 |
| style="text-align:right" | 0.0 |
||
| style="text-align:right" | -24 |
|||
|- |
|- |
||
| style="text-align:left" | Management actions, debt & other |
| style="text-align:left" | Management actions, debt & other |
||
| style="text-align:right" | +2 |
|||
| style="text-align:right" | -0.1 |
| style="text-align:right" | -0.1 |
||
| style="text-align:right" | -0.2 |
| style="text-align:right" | -0.2 |
||
| style="text-align:right" | +2 |
|||
|- |
|- |
||
| style="text-align:left" | FY25 |
| style="text-align:left" | '''FY25''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''224''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''56.4''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''25.2''' |
||
|} |
|} |
||
</div> |
</div> |
||
| Line 887: | Line 990: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Key sensitivities on Solvency II ratio |
|+ Key sensitivities on Solvency II ratio (224% at Dec 31, 2025) <sup>p. 24</sup> |
||
! style="text-align:left" | Sensitivity |
! style="text-align:left" | Sensitivity |
||
! class="col-s" style="text-align:right" | Impact (pts) |
! class="col-s" style="text-align:right" | Impact (pts) |
||
| Line 900: | Line 1,003: | ||
| style="text-align:right" | -1 |
| style="text-align:right" | -1 |
||
|- |
|- |
||
| style="text-align:left" | Euro Sovereign spreads +50bps |
| style="text-align:left" | Euro Sovereign spreads +50bps (1) |
||
| style="text-align:right" | -7 |
| style="text-align:right" | -7 |
||
|- |
|- |
||
| style="text-align:left" | Credit migration |
| style="text-align:left" | Credit migration (2) |
||
| style="text-align:right" | -4 |
| style="text-align:right" | -4 |
||
|- |
|- |
||
| Line 923: | Line 1,026: | ||
</div> |
</div> |
||
* Dividend & annual share buyback |
* Dividend & annual share buyback for EOF comprises foreseeable dividends of EUR -4.8bn and a provision for the 2026 annual share buyback of EUR -1.25bn. |
||
* 1 |
* '''Footnote 1''': Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures. |
||
* 2 |
* '''Footnote 2''': Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches). |
||
=== Solvency II -impact of the end of grandfathering period and Solvency II revision === |
=== Solvency II -impact of the end of grandfathering period and Solvency II revision === |
||
| Line 931: | Line 1,034: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Solvency II ratio |
|+ Solvency II ratio evolution to 1Q27 <sup>p. 25</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | — |
||
! class="col- |
! class="col-s" style="text-align:right" | Solvency II ratio |
||
|- |
|||
| style="text-align:left" | '''As of 31/12/2025''' |
|||
| style="text-align:right" | '''224%''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Impact of grandfathering period end (Jan 1, 2026) |
||
| style="text-align:right" | |
| style="text-align:right" | -10 pts |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''As of 01/01/2026''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''215%''' |
||
|- |
|- |
||
| style="text-align:left" | Impact of Solvency II revision |
| style="text-align:left" | Impact of Solvency II revision (effective 1Q27) |
||
| style="text-align:right" | + |
| style="text-align:right" | +17 pts |
||
|} |
|} |
||
</div> |
</div> |
||
* |
* The end of the grandfathering period is driven by EUR 2.4bn in grandfathered debt no longer being eligible as capital from that date. |
||
* No change expected in organic capital generation |
* No change is expected in organic capital generation from the Solvency II revision. |
||
* |
* The revision provides additional capital flexibility. |
||
* |
* The impact is estimated based on the Solvency Capital Requirement (SCR) and amount of capital (EOF) under Solvency II as of January 1, 2026, as if the revision had come into force on that date. |
||
=== Thomas Buberl, Group CEO conclusion === |
=== Thomas Buberl, Group CEO conclusion === |
||
| Line 971: | Line 1,077: | ||
=== AXA Investor Relations | Keep in touch === |
=== AXA Investor Relations | Keep in touch === |
||
<div style="overflow-x:auto"> |
|||
* '''Contact us''': <sup>p. 29</sup> |
|||
{| class="wikitable" |
|||
** Investor Relations +33 1 40 75 48 42 <sup>p. 29</sup> |
|||
|+ Upcoming events and contact information <sup>p. 29</sup> |
|||
! style="text-align:left" | Date |
|||
* '''Follow us''': www.axa.com <sup>p. 29</sup> |
|||
! class="col-m" style="text-align:right" | Event |
|||
* '''Upcoming events''': <sup>p. 29</sup> |
|||
! class="col-m" style="text-align:right" | Location |
|||
** March: Roadshows in Europe and US <sup>p. 29</sup> |
|||
|- |
|||
** May 5: 1Q25 Activity Indicators in Paris <sup>p. 29</sup> |
|||
| style="text-align:left" | March |
|||
** June 2: BNP Paribas Exane CEO Conference in Paris <sup>p. 29</sup> |
|||
| class="col-m" style="text-align:right" | Roadshows |
|||
** June 2-4: Goldman Sachs European Financials Conference in Zurich <sup>p. 29</sup> |
|||
| class="col-m" style="text-align:right" | Europe and US |
|||
** July 31: HY26 Earnings Release in Paris <sup>p. 29</sup> |
|||
|- |
|||
** September 21: AXA Investor Day in London <sup>p. 29</sup> |
|||
| style="text-align:left" | May 5 |
|||
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators |
|||
| class="col-m" style="text-align:right" | Paris |
|||
|- |
|||
| style="text-align:left" | June 2 |
|||
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference |
|||
| class="col-m" style="text-align:right" | Paris |
|||
|- |
|||
| style="text-align:left" | June 2-4 |
|||
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference |
|||
| class="col-m" style="text-align:right" | Zurich |
|||
|- |
|||
| style="text-align:left" | July 31 |
|||
| class="col-m" style="text-align:right" | HY26 Earnings Release |
|||
| class="col-m" style="text-align:right" | Paris |
|||
|- |
|||
| style="text-align:left" | September 21 |
|||
| class="col-m" style="text-align:right" | AXA Investor Day |
|||
| class="col-m" style="text-align:right" | London |
|||
|} |
|||
</div> |
|||
* '''Contact us''' <sup>p. 29</sup> |
|||
** '''Investor Relations phone''': +33 1 40 75 48 42 <sup>p. 29</sup> |
|||
** '''Investor Relations email''': investor.relations@axa.com <sup>p. 29</sup> |
|||
* '''Follow us''' <sup>p. 29</sup> |
|||
** '''Website''': www.axa.com <sup>p. 29</sup> |
|||
** Social media channels include YouTube, Facebook, Instagram, Twitter, and LinkedIn <sup>p. 29</sup> |
|||
* '''Meet our management (upcoming events)''' <sup>p. 29</sup> |
|||
* '''March''': Roadshows in Europe and US <sup>p. 29</sup> |
|||
== Appendices == |
== Appendices == |
||
| Line 993: | Line 1,128: | ||
=== Gross financial debt and maturity breakdown as of December 31st, 2025 === |
=== Gross financial debt and maturity breakdown as of December 31st, 2025 === |
||
All figures in EUR billion. <sup>p. 32</sup> |
|||
=== Gross financial debt === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Gross financial debt |
|+ Gross financial debt composition <sup>p. 32</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | FY24 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Jan 1, 2026 |
||
! class="col-s" style="text-align:right" | Total |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Senior debt |
||
| style="text-align:right" | 3.5 |
|||
| style="text-align:right" | 10.8 |
|||
| style="text-align:right" | 4.8 |
| style="text-align:right" | 4.8 |
||
| style="text-align:right" | |
| style="text-align:right" | 4.6 |
||
| style="text-align:right" | 3.2 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Tier 2 |
||
| style="text-align:right" | |
| style="text-align:right" | 10.8 |
||
| style="text-align:right" | 12.2 |
| style="text-align:right" | 12.2 |
||
| style="text-align:right" | |
| style="text-align:right" | 11.3 |
||
| style="text-align:right" | 22.3 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Tier 1 |
||
| style="text-align:right" | 3.5 |
|||
| style="text-align:right" | 3.5 |
|||
| style="text-align:right" | 5.8 |
| style="text-align:right" | 5.8 |
||
|- |
|||
| style="text-align:right" | 11.3 |
|||
| style="text-align: |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''19.2''' |
||
| style="text-align:right" | '''20.3''' |
|||
| style="text-align:right" | '''20.3''' |
|||
|} |
|} |
||
</div> |
</div> |
||
* '''Debt gearing''': 20.6% for FY24, 22.3% for FY25 <sup>p. 32</sup> |
|||
* An annotation notes "o/w €0.4bn redeemed in Jan 2026" <sup>p. 32</sup> |
|||
=== Contractual maturity breakdown === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Maturity profile of gross financial debt <sup>p. 32</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Total |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | o/w Grandfathered |
||
|- |
|||
! class="col-s" style="text-align:right" | Tier 1 |
|||
| style="text-align:left" | '''Tier 1''' |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | 2025 |
| style="text-align:left" | 2025 |
||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 0.5 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2028 |
||
| style="text-align:right" | 0.9 |
|||
| style="text-align:right" | 0.9 |
|||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2031-2039 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 0. |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | 0.5 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | ≥2040 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 0. |
| style="text-align:right" | 0.2 |
||
| style="text-align:right" | 0.5 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Undated |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.4 |
|||
|- |
|||
| style="text-align:left" | '''Tier 2''' |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | 2026 |
|||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 0.5 |
|||
|- |
|- |
||
| style="text-align:left" | 2030 |
| style="text-align:left" | 2030 |
||
| style="text-align:right" | 0.9 |
| style="text-align:right" | 0.9 |
||
| style="text-align:right" | 0. |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | 0.5 |
|||
|- |
|- |
||
| style="text-align:left" | 2031-2039 |
| style="text-align:left" | 2031-2039 |
||
| style="text-align:right" | |
| style="text-align:right" | 1.5 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 0.5 |
|||
|- |
|- |
||
| style="text-align:left" | ≥2040 |
| style="text-align:left" | ≥2040 |
||
| style="text-align:right" | 10.8 |
| style="text-align:right" | 10.8 |
||
| style="text-align:right" | 0.2 |
| style="text-align:right" | 0.2 |
||
| style="text-align:right" | 1.4 |
|||
|- |
|- |
||
| style="text-align:left" | Undated |
| style="text-align:left" | Undated |
||
| style="text-align:right" | 4.6 |
|||
| style="text-align:right" | 0.7 |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|} |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
|+ Grandfathered debt contractual maturity <sup>p. 32</sup> |
|||
! style="text-align:left" | EUR billion |
|||
! class="col-s" style="text-align:right" | Tier 1 |
|||
! class="col-s" style="text-align:right" | Tier 2 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Senior debt''' |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 0.2 |
|||
|- |
|||
| style="text-align:left" | ≥2040 |
|||
| style="text-align:right" | 0.2 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Undated |
| style="text-align:left" | Undated |
||
| style="text-align:right" | |
| style="text-align:right" | 4.6 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
</div> |
||
=== Economic maturity breakdown === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Maturity profile by instrument type <sup>p. 32</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Senior debt |
|||
! class="col-s" style="text-align:right" | Tier 2 |
|||
! class="col-s" style="text-align:right" | Tier 1 |
! class="col-s" style="text-align:right" | Tier 1 |
||
! class="col-s" style="text-align:right" | Tier 2 |
|||
! class="col-s" style="text-align:right" | Senior debt |
|||
! class="col-s" style="text-align:right" | Total |
|||
|- |
|- |
||
| style="text-align:left" | 2025 |
| style="text-align:left" | 2025 |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
|- |
|- |
||
| style="text-align:left" | 2026 |
| style="text-align:left" | 2026 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
|- |
|- |
||
| style="text-align:left" | 2027 |
| style="text-align:left" | 2027 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2.4 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2.4 |
| style="text-align:right" | 2.4 |
||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | 0.1 |
|||
|- |
|- |
||
| style="text-align:left" | 2028 |
| style="text-align:left" | 2028 |
||
| style="text-align:right" | 2.0 |
|||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | ~0.4 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | ~0.5 |
|||
|- |
|- |
||
| style="text-align:left" | 2029 |
| style="text-align:left" | 2029 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 2.0 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 2.0 |
|||
|- |
|- |
||
| style="text-align:left" | 2030 |
| style="text-align:left" | 2030 |
||
| style="text-align:right" | ~0.2 |
|||
| style="text-align:right" | 0.7 |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 0. |
| style="text-align:right" | ~0.9 |
||
|- |
|- |
||
| style="text-align:left" | 2031-2039 |
| style="text-align:left" | 2031-2039 |
||
| style="text-align:right" | 6.4 |
|||
| style="text-align:right" | 0.2 |
|||
| style="text-align:right" | 1.5 |
| style="text-align:right" | 1.5 |
||
| style="text-align:right" | 6.4 |
|||
| style="text-align:right" | -0.4 |
|||
| style="text-align:right" | 7.5 |
|||
|- |
|- |
||
| style="text-align:left" | ≥2040 |
| style="text-align:left" | ≥2040 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | 0.7 |
|||
|- |
|- |
||
| style="text-align:left" | Undated |
| style="text-align:left" | Undated |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | 0.7 |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | 4.0 |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
| Line 1,156: | Line 1,301: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Grandfathered debt economic maturity <sup>p. 32</sup> |
|+ o/w Grandfathered debt by economic maturity <sup>p. 32</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2026 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2028 |
||
! class="col-s" style="text-align:right" | 2030 |
|||
! class="col-s" style="text-align:right" | 2031-2039 |
|||
! class="col-s" style="text-align:right" | Undated |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Tier 1 |
||
| style="text-align:right" | 0. |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 0. |
| style="text-align:right" | 0.1 |
||
|- |
|||
| style="text-align:left" | ≥2040 |
|||
| style="text-align:right" | 0.2 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 0.4 |
|||
|- |
|||
| style="text-align:left" | Undated |
|||
| style="text-align:right" | 0.8 |
| style="text-align:right" | 0.8 |
||
|- |
|||
| style="text-align:left" | Tier 2 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 0.2 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
</div> |
||
=== Footnotes === |
|||
* Debt gearing: FY24 20.6%; FY25 22.3% <sup>p. 32</sup> |
|||
* In January 2026, AXA called the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 <sup>p. 32</sup> |
|||
* 1. Nominal debt <sup>p. 32</sup> |
|||
* In January 2026, AXA called the T1 GF €250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup> |
|||
* 2. In January 2026, AXA has called (i) the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF €250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup> |
|||
* Economic maturity takes into account the first date of step up calls on institutionally placed subordinated debt <sup>p. 32</sup> |
|||
* For Solvency 2 RT1 debt, the undated nature of the instrument is retained for this diagram, as |
* 3. Economic maturity takes into account the first date of step-up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, which has no step-up, the undated nature of the instrument is retained for this diagram. This should not be construed as an indication that the instrument will not be called for redemption when callable, as such decisions depend on capital, liquidity, and refinancing economics at the time <sup>p. 32</sup> |
||
* '''Jan 1st 2026''' (End of the grandfathering period): Total 20.3; Tier 1 5.8 (o/w EUR 0.4bn redeemed in Jan 2026); Tier 2 11.3; Senior debt 3.2 <sup>p. 32</sup> |
|||
=== General Account invested assets === |
=== General Account invested assets === |
||
| Line 1,186: | Line 1,335: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ General Account invested assets breakdown, FY25 <sup>p. 33</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Value |
||
! class="col-s" style="text-align:right" | Share of total |
|||
|- |
|- |
||
| style="text-align:left" | Fixed income |
| style="text-align:left" | '''Fixed income''' |
||
| style="text-align:right" | 345 |
| style="text-align:right" | '''345''' |
||
| style="text-align:right" | 77% |
| style="text-align:right" | '''77%''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Government bonds |
||
| style="text-align:right" | |
| style="text-align:right" | 167 |
||
| style="text-align:right" | |
| style="text-align:right" | 37% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Corporate bonds and loans |
||
| style="text-align:right" | |
| style="text-align:right" | 121 |
||
| style="text-align:right" | |
| style="text-align:right" | 27% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other fixed income |
||
| style="text-align:right" | |
| style="text-align:right" | 56 |
||
| style="text-align:right" | |
| style="text-align:right" | 13% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Real estate''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''41''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''9%''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Private equity and hedge funds''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''23''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''5%''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Cash''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''19''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''4%''' |
||
|- |
|||
| style="text-align:left" | '''Infrastructure equity''' |
|||
| style="text-align:right" | '''10''' |
|||
| style="text-align:right" | '''2%''' |
|||
|- |
|||
| style="text-align:left" | '''Listed equities''' |
|||
| style="text-align:right" | '''10''' |
|||
| style="text-align:right" | '''2%''' |
|||
|- |
|||
| style="text-align:left" | '''Policy loans''' |
|||
| style="text-align:right" | '''2''' |
|||
| style="text-align:right" | '''0%''' |
|||
|- |
|- |
||
| style="text-align:left" | '''Total Insurance Invested Assets''' |
| style="text-align:left" | '''Total Insurance Invested Assets''' |
||
| Line 1,223: | Line 1,385: | ||
|} |
|} |
||
</div> |
</div> |
||
* FY25 Total General Account invested assets: EUR 450bn, with a duration gap of -0.4 year. |
|||
* Other fixed income (EUR 56bn) includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn). |
|||
* Duration gap: -0.4 year <sup>p. 33</sup> |
|||
* Listed equities figure (EUR 10bn) includes hedges; excluding hedges, the value is EUR 14bn. |
|||
* o/w Government bonds: 167 (37%) <sup>p. 33</sup> |
|||
* Private equity and hedge funds (EUR 23bn) includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn). |
|||
* o/w Corporate bonds and loans: 121 (27%) <sup>p. 33</sup> |
|||
* A note indicates to refer to the financial supplement for more details. |
|||
* o/w Other fixed income: 56 (13%) <sup>p. 33</sup> |
|||
** Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup> |
|||
* Listed equities includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup> |
|||
* Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) <sup>p. 33</sup> |
|||
* Refer to the financial supplement for more details <sup>p. 33</sup> |
|||
=== Structured and Private Credit assets === |
=== Structured and Private Credit assets === |
||
| Line 1,237: | Line 1,395: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Structured and private credit assets in the General Account (G/A) portfolio <sup>p. 34</sup> |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Value |
||
! class="col-s" style="text-align:right" | % of G/A portfolio |
|||
! class="col-m" style="text-align:right" | Notes |
|||
|- |
|||
| style="text-align:left" | CLO & ABS |
|||
| style="text-align:right" | 25 |
|||
| style="text-align:right" | 6% |
|||
| style="text-align:right" | 91% senior CLOs (~40% subordination); 100% AAA-A rated (92% AAA-AA). |
|||
|- |
|- |
||
| style="text-align:left" | Residential Mortgages |
| style="text-align:left" | Residential Mortgages |
||
| style="text-align:right" | 16 |
| style="text-align:right" | 16 |
||
| style="text-align:right" | 4% |
| style="text-align:right" | 4% |
||
| style="text-align:right" | Incl. EUR 6bn NHG-guaranteed (Dutch) and EUR 10bn self-originated in CH (56% LTV) & DE (45% LTV). |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Mid-Market lending |
||
| style="text-align:right" | |
| style="text-align:right" | 10 |
||
| style="text-align:right" | |
| style="text-align:right" | 2% |
||
| style="text-align:right" | EUR 8m average ticket size; via SMAs with strict underwriting. |
|||
|- |
|- |
||
| style="text-align:left" | Infrastructure debt |
| style="text-align:left" | Infrastructure debt |
||
| style="text-align:right" | 8 |
| style="text-align:right" | 8 |
||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
| style="text-align:right" | Skewed towards Telecom, Utilities, and Transport. |
|||
|- |
|- |
||
| style="text-align:left" | CRE debt |
| style="text-align:left" | CRE debt |
||
| style="text-align:right" | 8 |
| style="text-align:right" | 8 |
||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
| style="text-align:right" | Mainly logistics, residential, retail; mostly Europe; ~60% LTV. |
|||
|- |
|||
| style="text-align:left" | Mid-Market lending |
|||
| style="text-align:right" | 10 |
|||
| style="text-align:right" | 2% |
|||
|- |
|- |
||
| style="text-align:left" | Other |
| style="text-align:left" | Other |
||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
| style="text-align:right" | 0% |
| style="text-align:right" | 0% |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | '''Total Structured and Private Credit Assets''' |
| style="text-align:left" | '''Total Structured and Private Credit Assets''' |
||
| style="text-align:right" | '''69''' |
| style="text-align:right" | '''69''' |
||
| style="text-align:right" | '''15%''' |
| style="text-align:right" | '''15%''' |
||
| style="text-align:right" | 54% is participating. |
|||
|} |
|} |
||
</div> |
</div> |
||
* Footnote: G/A stands for General Account. |
|||
* |
* Skewed towards resilient industries such as Telecom, Utilities, and Transport <sup>p. 34</sup>. |
||
* |
* Features strong sector diversification, mainly in logistics, residential, and retail <sup>p. 34</sup>. |
||
* Investments are made through Separately Managed Accounts (SMAs) with strict underwriting guidelines, including senior secured status, covenants, and restrictions on asset sales and sector allocation <sup>p. 34</sup>. |
|||
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 93% rated AAA-AA) <sup>p. 34</sup> |
|||
* Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 34</sup> |
|||
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup> |
|||
* Strong diversification with EUR 8m average ticket <sup>p. 34</sup> |
|||
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 34</sup> |
|||
* o/w 54% participating <sup>p. 34</sup> |
|||
* G/A: General Account <sup>p. 34</sup> |
|||
=== Investment portfolio | Fixed Income reinvestment === |
=== Investment portfolio | Fixed Income reinvestment === |
||
| Line 1,285: | Line 1,446: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Reinvestment breakdown by asset class, FY25 <sup>p. 35</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Asset class |
||
! class="col-s" style="text-align:right" | Share |
! class="col-s" style="text-align:right" | Share |
||
|- |
|||
! class="col-s" style="text-align:right" | Average rating |
|||
| style="text-align:left" | Investment grade credit |
|||
| style="text-align:right" | 40% |
|||
|- |
|- |
||
| style="text-align:left" | Government bonds & related |
| style="text-align:left" | Government bonds & related |
||
| style="text-align:right" | 32% |
| style="text-align:right" | 32% |
||
| style="text-align:right" | AA |
|||
| style="text-align:right" | 3.5% |
|||
|- |
|||
| style="text-align:left" | Investment grade credit |
|||
| style="text-align:right" | 40% |
|||
| style="text-align:right" | A |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | ABS/CLO/IG fund financing |
| style="text-align:left" | ABS/CLO/IG fund financing |
||
| style="text-align:right" | 21% |
| style="text-align:right" | 21% |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Below investment grade credit |
| style="text-align:left" | Below investment grade credit |
||
| style="text-align:right" | 7% |
| style="text-align:right" | 7% |
||
|} |
|||
| style="text-align:right" | — |
|||
</div> |
|||
| style="text-align:right" | — |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
|+ FY25 fixed income reinvestment yield <sup>p. 35</sup> |
|||
! style="text-align:left" | Fixed income type |
|||
! class="col-s" style="text-align:right" | Yield |
|||
|- |
|- |
||
| style="text-align:left" | Public fixed income |
| style="text-align:left" | Public fixed income |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 3.5% |
| style="text-align:right" | 3.5% |
||
|- |
|- |
||
| style="text-align:left" | Private & Structured fixed income |
| style="text-align:left" | Private & Structured fixed income |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4.7% |
| style="text-align:right" | 4.7% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left; font-weight:bold" | Total fixed income |
||
| style="text-align:right" | |
| style="text-align:right; font-weight:bold" | 3.9% |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | '''3.9%''' |
|||
|} |
|} |
||
</div> |
</div> |
||
* |
* Total FY25 fixed income reinvestment of EUR 57 billion, invested at an average yield of 3.9% with an average duration of 9 years <sup>p. 35</sup>. |
||
* The reinvestment includes EUR 19.7 billion of Private & Structured Credit invested at 4.7%, which comprises CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY <sup>p. 35</sup>. |
|||
** Average duration of 9 years <sup>p. 35</sup> |
|||
* A gradual shift is occurring from alternative total return assets to Private & Structured credit <sup>p. 35</sup>. |
|||
** Includes EUR 19.7 billion of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) <sup>p. 35</sup> |
|||
* ¹ Footnote: Government and Corporate bonds and related <sup>p. 35</sup>. |
|||
* ² Footnote: Private & Structured credit includes CLOs, ABS, Infra & CRE debt, Fund financing, and Private hybrid <sup>p. 35</sup>. |
|||
* Government and Corporate bonds and related <sup>p. 35</sup> |
|||
* Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) <sup>p. 35</sup> |
|||
<div style="overflow-x:auto"> |
|||
* '''Table of contents''': |
|||
{| class="wikitable" |
|||
** 1. Debt and Invested Assets, p.31 <sup>p. 36</sup> |
|||
|+ Appendix table of contents <sup>p. 36</sup> |
|||
! style="text-align:left" | Section |
|||
** 3. Additional IFRS17 disclosures, p.41 <sup>p. 36</sup> |
|||
! class="col-m" style="text-align:right" | Title |
|||
** 4. Sustainability, p.44 <sup>p. 36</sup> |
|||
! class="col-xs" style="text-align:right" | Page |
|||
|- |
|||
| style="text-align:left" | 1 |
|||
| class="col-m" style="text-align:right" | Debt and Invested Assets |
|||
| class="col-xs" style="text-align:right" | 31 |
|||
|- |
|||
| style="text-align:left" | 2 |
|||
| class="col-m" style="text-align:right" | Additional P&C disclosures |
|||
| class="col-xs" style="text-align:right" | 36 |
|||
|- |
|||
| style="text-align:left" | 3 |
|||
| class="col-m" style="text-align:right" | Additional IFRS17 disclosures |
|||
| class="col-xs" style="text-align:right" | 41 |
|||
|- |
|||
| style="text-align:left" | 4 |
|||
| class="col-m" style="text-align:right" | Sustainability |
|||
| class="col-xs" style="text-align:right" | 44 |
|||
|} |
|||
</div> |
|||
* This slide presents the table of contents for the appendix or additional disclosures section. <sup>p. 36</sup> |
|||
* The slide is marked as "GIE_AXA_Confidential". <sup>p. 36</sup> |
|||
=== AXA XL Insurance | Large Commercial & Specialty business === |
=== AXA XL Insurance | Large Commercial & Specialty business === |
||
| Line 1,345: | Line 1,518: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ FY25 GWP by line of business |
|+ FY25 GWP by line of business, USD 19bn total <sup>p. 37</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Line of business |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Share |
||
! class="col-s" style="text-align:right" | Geography share |
|||
|- |
|- |
||
| style="text-align:left" | Casualty |
| style="text-align:left" | Casualty |
||
| style="text-align:right" | 35% |
| style="text-align:right" | 35% |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Property |
| style="text-align:left" | Property |
||
| style="text-align:right" | 29% |
| style="text-align:right" | 29% |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Specialty |
| style="text-align:left" | Specialty |
||
| style="text-align:right" | 19% |
| style="text-align:right" | 19% |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Professional lines |
| style="text-align:left" | Professional lines |
||
| style="text-align:right" | 17% |
| style="text-align:right" | 17% |
||
|} |
|||
| style="text-align:right" | — |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
|+ FY25 GWP by geography, USD 19bn total <sup>p. 37</sup> |
|||
! style="text-align:left" | Geography |
|||
! class="col-s" style="text-align:right" | Share |
|||
|- |
|- |
||
| style="text-align:left" | Americas |
| style="text-align:left" | Americas |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 46% |
| style="text-align:right" | 46% |
||
|- |
|- |
||
| style="text-align:left" | Europe & APAC |
| style="text-align:left" | Europe & APAC |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 35% |
| style="text-align:right" | 35% |
||
|- |
|- |
||
| style="text-align:left" | UK & Lloyds |
| style="text-align:left" | UK & Lloyds |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 19% |
| style="text-align:right" | 19% |
||
|} |
|} |
||
</div> |
</div> |
||
* Well diversified across lines of business and geographies <sup>p. 37</sup> |
* '''Well diversified across lines of business and geographies''' <sup>p. 37</sup> |
||
* Leading market positions across lines <sup>p. 37</sup> |
* '''Leading market positions across lines''' <sup>p. 37</sup> |
||
** Top 3 globally |
** '''Top 3 globally''' in: |
||
** Multinational Programs <sup>p. 37</sup> |
*** Multinational Programs² <sup>p. 37</sup> |
||
** Marine <sup>p. 37</sup> |
*** Marine³ <sup>p. 37</sup> |
||
** Fine Art & |
*** Fine Art & Specie⁴ <sup>p. 37</sup> |
||
* Managing the cycle to deliver consistent profitability <sup>p. 37</sup> |
* '''Managing the cycle to deliver consistent profitability''' <sup>p. 37</sup> |
||
** (scatter plot) '''Profitability |
** (scatter plot) '''Relative positioning of business lines''' by Profitability (Y-axis) and Ex-price growth % (X-axis) <sup>p. 37</sup>: |
||
*** Property |
*** '''Property''': Highest profitability and highest ex-price growth <sup>p. 37</sup> |
||
*** Specialty |
*** '''Specialty''': High profitability and high ex-price growth <sup>p. 37</sup> |
||
*** Casualty |
*** '''Casualty''': Medium profitability and medium ex-price growth <sup>p. 37</sup> |
||
*** Professional lines |
*** '''Professional lines''': Lowest profitability and lowest ex-price growth <sup>p. 37</sup> |
||
* '''Footnotes''': 1. Including Cyber; 2. Source: McKinsey; 3. Source: Aon, Guy Carpenter, and Global Market Insights; 4. Source: Industry Research Biz (January 2026) <sup>p. 37</sup> |
|||
=== P&C | Focus on Reserves === |
=== P&C | Focus on Reserves === |
||
* (bar chart) '''Claims reserves ratio''' (Net undiscounted claims reserves / Net earned premiums) <sup>p. 38</sup> |
|||
<div style="overflow-x:auto"> |
|||
** '''IFRS4 basis''': FY18 179%, FY19 185%, FY20 193%, FY21 188%, FY22 189% <sup>p. 38</sup> |
|||
{| class="wikitable fintable" |
|||
** '''IFRS17 basis''': FY22 198%, FY23 195%, FY24 180%, FY25 175% <sup>p. 38</sup> |
|||
* (bar chart) '''Technical reserves ratio''' (Net undiscounted technical reserves¹ / Net earned premiums) <sup>p. 38</sup> |
|||
! style="text-align:left" | % |
|||
** '''IFRS4 basis''': FY18 213%, FY19 227%, FY20 233%, FY21 226%, FY22 227% <sup>p. 38</sup> |
|||
! class="col-s" style="text-align:right" | Claims reserves ratio (IFRS4) |
|||
** '''IFRS17 basis''': FY22 234%, FY23 232%, FY24 216%, FY25 210% <sup>p. 38</sup> |
|||
! class="col-s" style="text-align:right" | Claims reserves ratio (IFRS17) |
|||
* ¹Includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>. |
|||
! class="col-s" style="text-align:right" | Technical reserves ratio (IFRS4) |
|||
! class="col-s" style="text-align:right" | Technical reserves ratio (IFRS17) |
|||
|- |
|||
| style="text-align:left" | FY18 |
|||
| style="text-align:right" | 179% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 213% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | FY19 |
|||
| style="text-align:right" | 185% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 227% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | FY20 |
|||
| style="text-align:right" | 193% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 233% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | FY21 |
|||
| style="text-align:right" | 188% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 226% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | FY22 |
|||
| style="text-align:right" | 189% |
|||
| style="text-align:right" | 198% |
|||
| style="text-align:right" | 227% |
|||
| style="text-align:right" | 234% |
|||
|- |
|||
| style="text-align:left" | FY23 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 195% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 232% |
|||
|- |
|||
| style="text-align:left" | FY24 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 180% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 216% |
|||
|- |
|||
| style="text-align:left" | FY25 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 175% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 210% |
|||
|} |
|||
</div> |
|||
* '''Claims reserves ratio''' (Net undiscounted claims reserves/Net earned premiums) <sup>p. 38</sup> |
|||
* '''Technical reserves ratio''' (Net undiscounted technical reserves /Net earned premiums) <sup>p. 38</sup> |
|||
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 === |
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 === |
||
| Line 1,459: | Line 1,580: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Insurance segment |
|+ Insurance segment capacity and retention by peril <sup>p. 39</sup> |
||
! style="text-align:left" | EUR |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | Capacity |
! class="col-s" style="text-align:right" | Capacity |
||
! class="col-s" style="text-align:right" | Retention |
! class="col-s" style="text-align:right" | Retention |
||
|- |
|- |
||
| style="text-align:left" | EU Windstorm |
| style="text-align:left" | EU Windstorm |
||
| style="text-align:right" | 4 |
| style="text-align:right" | 4,000 |
||
| style="text-align:right" | |
| style="text-align:right" | 600 |
||
|- |
|- |
||
| style="text-align:left" | Europe Flood |
| style="text-align:left" | Europe Flood |
||
| style="text-align:right" | 2 |
| style="text-align:right" | 2,100 |
||
| style="text-align:right" | |
| style="text-align:right" | 450 |
||
|- |
|- |
||
| style="text-align:left" | Europe Earthquake |
| style="text-align:left" | Europe Earthquake |
||
| style="text-align:right" | 2 |
| style="text-align:right" | 2,100 |
||
| style="text-align:right" | |
| style="text-align:right" | 400 |
||
|- |
|- |
||
| style="text-align:left" | NA Hurricane |
| style="text-align:left" | NA Hurricane |
||
| style="text-align:right" | 1 |
| style="text-align:right" | 1,200 |
||
| style="text-align:right" | |
| style="text-align:right" | 600 |
||
|- |
|- |
||
| style="text-align:left" | NA Earthquake |
| style="text-align:left" | NA Earthquake |
||
| style="text-align:right" | 1 |
| style="text-align:right" | 1,200 |
||
| style="text-align:right" | |
| style="text-align:right" | 600 |
||
|- |
|- |
||
| style="text-align:left" | Per other perils |
| style="text-align:left" | Per other perils |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 400 |
||
|} |
|} |
||
</div> |
</div> |
||
* All figures are in Euro. |
|||
* Stable retention levels maintained in 2026 as in 2025 |
* Stable retention levels will be maintained in 2026 as in 2025. |
||
* (diagram) '''Reinsurance segment (illustrative)''' |
* (diagram) '''Reinsurance segment (illustrative)''' is comprised of Alternative Capital & Cat Bonds. |
||
* |
* The program excludes local reinsurance covers. |
||
* |
* There is varying retention between Mexico (MX) and North America (NA): EUR 400m for MX and EUR 600m for NA. |
||
* |
* "Other perils" include Turkey earthquake, other Europe and NA perils, South America Earthquake, and a series of other secondary perils. Capacity varies by peril type. |
||
* '''EU Windstorm''': Capacity EUR 4.0bn, Retention EUR 600m <sup>p. 39</sup>. |
|||
* '''Europe Flood''': Capacity EUR 2.1bn, Retention EUR 450m <sup>p. 39</sup>. |
|||
* '''Europe Earthquake''': Capacity EUR 2.1bn, Retention EUR 400m <sup>p. 39</sup>. |
|||
* '''NA Hurricane''': Capacity EUR 1.2bn, Retention EUR 600m <sup>p. 39</sup>. |
|||
* '''NA Earthquake''': Capacity EUR 1.2bn, Retention EUR 600m <sup>p. 39</sup>. |
|||
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 === |
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 === |
||
Caption: Natural catastrophe charge scenarios and expectations <sup>p. 40</sup> |
|||
* '''Group underlying earnings deviation to average Nat Cat charges in 2026''' |
|||
* (net of reinsurance, post-tax) |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
|+ Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax <sup>p. 40</sup> |
|||
! style="text-align:left" | Percentile |
|||
! class="col-s" style="text-align:right" | Deviation |
! class="col-s" style="text-align:right" | Deviation |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''More severe years (negative deviation in ca. 40% of cases)''' |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | 1/ |
| style="text-align:left" | 1/20y event (95th percentile) |
||
| |
| style="text-align:right" | -1.2 |
||
|- |
|- |
||
| style="text-align:left" | 1/ |
| style="text-align:left" | 1/10y event (90th percentile) |
||
| |
| style="text-align:right" | -0.8 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1/5y event (80th percentile) |
||
| |
| style="text-align:right" | -0.4 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Median (50th percentile)''' |
||
| |
| style="text-align:right" | +0.1 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Less severe years (positive deviation in ca. 60% of cases)''' |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | 1/ |
| style="text-align:left" | 1/5y event (20th percentile) |
||
| |
| style="text-align:right" | +0.5 |
||
|- |
|||
| style="text-align:left" | 1/10y event (10th percentile) |
|||
| style="text-align:right" | +0.7 |
|||
|- |
|||
| style="text-align:left" | 1/20y event (5th percentile) |
|||
| style="text-align:right" | +0.8 |
|||
|} |
|} |
||
</div> |
</div> |
||
* '''Average Expected Nat Cat charges''' |
|||
* (net of reinsurance, pre-tax) |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| class="wikitable" |
||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
|+ Average Expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup> |
|||
! style="text-align: |
! class="col-xs" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-xs" style="text-align:right" | 2026 |
||
! class="col-s" style="text-align:right" | 2026 |
|||
|- |
|- |
||
| style="text-align:left" | Average Expected Nat Cat charges |
| style="text-align:left" | Average Expected Nat Cat charges |
||
| style="text-align:right" | 2.6 |
| class="col-xs" style="text-align:right" | 2.6 |
||
| style="text-align:right" | 2.7 |
| class="col-xs" style="text-align:right" | 2.7 |
||
|- |
|- |
||
| style="text-align:left" | Estimated impact on GEP |
| style="text-align:left" | Estimated impact on GEP |
||
| style="text-align:right" | 4.5% |
| class="col-xs" style="text-align:right" | ca. 4.5% |
||
| style="text-align:right" | 4.5% |
| class="col-xs" style="text-align:right" | ca. 4.5% |
||
|} |
|} |
||
</div> |
</div> |
||
* All figures in EUR billion, net of reinsurance. |
|||
* Natural catastrophe cost is defined as the Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. The deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). |
|||
* 1. Debt and Invested Assets, p.31 <sup>p. 41</sup> |
|||
* Footnote 1: Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). |
|||
* 2. Additional P&C disclosures, p.36 <sup>p. 41</sup> |
|||
* (bar) '''More severe years (Negative deviation in ca. 40% of cases)''': |
|||
* 3. Additional IFRS17 disclosures, p.41 <sup>p. 41</sup> |
|||
* (bar) '''Less severe years (Positive deviation in ca. 60% of cases)''': |
|||
* 4. Sustainability, p.44 <sup>p. 41</sup> |
|||
* '''Table of contents''' <sup>p. 41</sup> |
|||
** 1. Debt and Invested Assets <sup>p. 31</sup> |
|||
** 2. Additional P&C disclosures <sup>p. 36</sup> |
|||
** 3. Additional IFRS17 disclosures <sup>p. 41</sup> |
|||
** 4. Sustainability <sup>p. 44</sup> |
|||
=== P&C | Margin analysis === |
=== P&C | Margin analysis === |
||
* (flow) The slide presents a flow diagram detailing the components of the P&C Technical and Financial results, which sum to Underlying Earnings before tax. All changes are versus FY24 at constant FX <sup>p. 42</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ P&C Underlying Earnings |
|+ P&C Underlying Earnings buildup, FY25 vs FY24 <sup>p. 42</sup> |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change vs FY24 |
||
|- |
|- |
||
| style="text-align:left" | '''Technical Result''' |
| style="text-align:left" | '''Technical Result''' |
||
| Line 1,570: | Line 1,704: | ||
| style="text-align:right" | 2,778 |
| style="text-align:right" | 2,778 |
||
| style="text-align:right" | +707 |
| style="text-align:right" | +707 |
||
|- |
|||
| style="text-align:left" | Gross Earned Premiums |
|||
| style="text-align:right" | 57,656 |
|||
| style="text-align:right" | +6% |
|||
|- |
|||
| style="text-align:left" | Current Accident Year Undiscounted Combined Ratio |
|||
| style="text-align:right" | 95.2% |
|||
| style="text-align:right" | -1.0pt |
|||
|- |
|||
| style="text-align:left; padding-left:1.5em" | o/w Nat Cats |
|||
| style="text-align:right" | 3.4% |
|||
| style="text-align:right" | -0.4pt |
|||
|- |
|- |
||
| style="text-align:left" | Current Accident Year Discounting |
| style="text-align:left" | Current Accident Year Discounting |
||
| style="text-align:right" | 2,009 |
| style="text-align:right" | 2,009 |
||
| style="text-align:right" | +115 |
| style="text-align:right" | +115 |
||
|- |
|||
| style="text-align:left" | Discounting Ratio (in Combined Ratio points) |
|||
| style="text-align:right" | -3.5% |
|||
| style="text-align:right" | +0.0pt |
|||
|- |
|||
| style="text-align:left" | Current Accident Year Net Claims reserves |
|||
| style="text-align:right" | 19.0bn |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Duration |
|||
| style="text-align:right" | 4.0 years |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Current Accident Year Discount Rate |
|||
| style="text-align:right" | 2.8% |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Prior Years' Reserve Development (PYD) |
| style="text-align:left" | Prior Years' Reserve Development (PYD) |
||
| style="text-align:right" | 622 |
| style="text-align:right" | 622 |
||
| style="text-align:right" | -341 |
| style="text-align:right" | -341 |
||
|- |
|||
| style="text-align:left" | PYD ratio |
|||
| style="text-align:right" | -1.1% |
|||
| style="text-align:right" | +0.7pt |
|||
|- |
|- |
||
| style="text-align:left" | '''Financial Result''' |
| style="text-align:left" | '''Financial Result''' |
||
| Line 1,618: | Line 1,720: | ||
| style="text-align:right" | 3,988 |
| style="text-align:right" | 3,988 |
||
| style="text-align:right" | +435 |
| style="text-align:right" | +435 |
||
|- |
|||
| style="text-align:left" | FY25 Average Assets |
|||
| style="text-align:right" | 115bn |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Asset book yield |
|||
| style="text-align:right" | 3.5% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | FY25 Reinvestment yield |
|||
| style="text-align:right" | 4.3% |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Insurance Finance Expenses |
| style="text-align:left" | Insurance Finance Expenses |
||
| style="text-align:right" | -1,358 |
| style="text-align:right" | -1,358 |
||
| style="text-align:right" | -235 |
| style="text-align:right" | -235 |
||
|- |
|||
| style="text-align:left" | FY24 Reserves at locked-in rate |
|||
| style="text-align:right" | 71bn |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Liability book yield |
|||
| style="text-align:right" | 1.9% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | 2025 Insurance Finance Expenses (pre-tax) |
|||
| style="text-align:right" | ~-1.4bn |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | '''Underlying Earnings before tax''' |
| style="text-align:left" | '''Underlying Earnings before tax''' |
||
| style="text-align:right" | 8,040 |
| style="text-align:right" | '''8,040''' |
||
| style="text-align:right" | +681 |
| style="text-align:right" | '''+681''' |
||
|- |
|- |
||
| style="text-align:left" | Tax |
| style="text-align:left" | Tax |
||
| Line 1,660: | Line 1,738: | ||
|- |
|- |
||
| style="text-align:left" | '''Underlying Earnings''' |
| style="text-align:left" | '''Underlying Earnings''' |
||
| style="text-align:right" | 5,872 |
| style="text-align:right" | '''5,872''' |
||
| style="text-align:right" | +501 |
| style="text-align:right" | '''+501''' |
||
|- |
|||
| style="text-align:left" | Growth vs. FY24 (at constant FX) |
|||
| style="text-align:right" | +9% |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
* '''Supporting Metrics & Details:''' |
|||
** Gross Earned Premiums: EUR 57,656m, +6% |
|||
** Current Accident Year Undiscounted Combined Ratio: 95.2%, -1.0pt |
|||
*** of which Nat Cats: 3.4%, -0.4pt |
|||
** Discounting Ratio (in Combined Ratio points): -3.5%, +0.0pt |
|||
** Current Accident Year Net Claims reserves: EUR 19.0bn |
|||
** Duration: 4.0 years |
|||
** Current Accident Year Discount rate: 2.8% |
|||
** PYD ratio: -1.1%, +0.7pt |
|||
** FY25 Average Assets: EUR 115bn |
|||
** Asset book yield: 3.5% |
|||
** FY25 Reinvestment yield on fixed income assets: 4.3% |
|||
** FY24 Reserves at locked-in rate: EUR 71bn |
|||
** Liability book yield: 1.9% |
|||
** Underlying Earnings Growth vs. FY24 (at constant FX): +9% |
|||
** 2026e Insurance Finance Expenses (pre-tax): ~-EUR 1.4bn |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| class="wikitable" |
||
|+ |
|+ FY25 sensitivity to Current Accident Year discount rate changes <sup>p. 42</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Scenario |
||
! class="col-s" style="text-align:right" | Impact |
! class="col-s" style="text-align:right" | Impact |
||
|- |
|- |
||
| style="text-align:left" | +25bps |
| style="text-align:left" | +25bps |
||
| style="text-align:right" | +0. |
| class="col-s" style="text-align:right" | +EUR 0.2bn |
||
|- |
|- |
||
| style="text-align:left" | -25bps |
| style="text-align:left" | -25bps |
||
| style="text-align:right" | -0. |
| class="col-s" style="text-align:right" | -EUR 0.2bn |
||
|} |
|} |
||
</div> |
</div> |
||
* ''Based on a parallel shift of the full-year average yield curve used for discounting FY25 current accident year net reserve.'' |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
|+ Sensitivity of |
|+ Sensitivity of 2026e Insurance Finance Expenses <sup>p. 42</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Scenario |
||
! class="col-s" style="text-align:right" | Impact |
! class="col-s" style="text-align:right" | Impact |
||
|- |
|- |
||
| style="text-align:left" | +25bps |
| style="text-align:left" | +25bps |
||
| class="col-s" style="text-align:right" | ~- |
| class="col-s" style="text-align:right" | ~-EUR 50m |
||
|- |
|- |
||
| style="text-align:left" | -25bps |
| style="text-align:left" | -25bps |
||
| class="col-s" style="text-align:right" | ~+ |
| class="col-s" style="text-align:right" | ~+EUR 50m |
||
|} |
|} |
||
</div> |
</div> |
||
* ''Sensitivity to changes in 2025 current AY Discount.'' |
|||
* Changes versus FY24 at constant FX <sup>p. 42</sup> |
|||
* Reinvestment yield on fixed income assets <sup>p. 42</sup> |
|||
* Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve <sup>p. 42</sup> |
|||
* (flow) '''Technical Result''' (In Euro million, pre-tax) <sup>p. 42</sup> |
|||
* (flow) '''Financial Result''' (In Euro million, pre-tax) <sup>p. 42</sup> |
|||
* (flow) '''Underlying Earnings before tax''' <sup>p. 42</sup> |
|||
=== L&H | Margin analysis === |
=== L&H | Margin analysis === |
||
* Includes scope impact <sup>p. 43</sup> |
|||
* Changes versus FY24 at constant FX <sup>p. 43</sup> |
|||
* Reinvestment yield on fixed income assets <sup>p. 43</sup> |
|||
* Incl. recapture of Laya <sup>p. 43</sup> |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Life & Health Underlying Earnings buildup, FY25 vs FY24 <sup>p. 43</sup> |
||
! style="text-align:left" | EUR million unless otherwise mentioned |
! style="text-align:left" | EUR million unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change vs FY24 |
||
|- |
|- |
||
| style="text-align:left" | '''Technical Result''' |
| style="text-align:left" | '''Technical Result''' |
||
| Line 1,720: | Line 1,811: | ||
| style="text-align:right" | 479 |
| style="text-align:right" | 479 |
||
| style="text-align:right" | +60 |
| style="text-align:right" | +60 |
||
|- |
|||
| style="text-align:left" | Gross Earned Premiums |
|||
| style="text-align:right" | 17,416 |
|||
| style="text-align:right" | +10% |
|||
|- |
|||
| style="text-align:left" | All Year Combined Ratio |
|||
| style="text-align:right" | 97.2% |
|||
| style="text-align:right" | -0.1pts |
|||
|- |
|- |
||
| style="text-align:left" | Long-term Technical Margin |
| style="text-align:left" | Long-term Technical Margin |
||
| style="text-align:right" | 2,804 |
| style="text-align:right" | 2,804 |
||
| style="text-align:right" | +156 |
| style="text-align:right" | +156 |
||
|- |
|||
| style="text-align:left" | CSM release |
|||
| style="text-align:right" | 2,954 |
|||
| style="text-align:right" | +215 |
|||
|- |
|||
| style="text-align:left" | Technical experience |
|||
| style="text-align:right" | -150 |
|||
| style="text-align:right" | -58 |
|||
|- |
|- |
||
| style="text-align:left" | '''Financial Result''' |
| style="text-align:left" | '''Financial Result''' |
||
| Line 1,748: | Line 1,823: | ||
| style="text-align:right" | 2,484 |
| style="text-align:right" | 2,484 |
||
| style="text-align:right" | -1 |
| style="text-align:right" | -1 |
||
|- |
|||
| style="text-align:left" | FY25 Average Assets |
|||
| style="text-align:right" | 98bn |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Asset book yield |
|||
| style="text-align:right" | 2.5% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | FY25 Reinvestment yield |
|||
| style="text-align:right" | 3.8% |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Insurance Finance Expenses (non-VFA only) |
| style="text-align:left" | Insurance Finance Expenses (non-VFA only) |
||
| style="text-align:right" | -1,538 |
| style="text-align:right" | -1,538 |
||
| style="text-align:right" | -9 |
| style="text-align:right" | -9 |
||
|- |
|||
| style="text-align:left" | FY24 Reserves at locked-in rate |
|||
| style="text-align:right" | 62bn |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Liability book yield |
|||
| style="text-align:right" | 2.5% |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | '''Underlying Earnings before tax''' |
| style="text-align:left" | '''Underlying Earnings before tax''' |
||
| style="text-align:right" | 4,229 |
| style="text-align:right" | '''4,229''' |
||
| style="text-align:right" | +205 |
| style="text-align:right" | '''+205''' |
||
|- |
|- |
||
| style="text-align:left" | Tax |
| style="text-align:left" | Tax |
||
| Line 1,786: | Line 1,841: | ||
|- |
|- |
||
| style="text-align:left" | '''Underlying Earnings''' |
| style="text-align:left" | '''Underlying Earnings''' |
||
| style="text-align:right" | 3,501 |
| style="text-align:right" | '''3,501''' |
||
| style="text-align:right" | +219 |
| style="text-align:right" | '''+219''' |
||
|- |
|||
| style="text-align:left" | Growth vs. FY24 (at constant FX) |
|||
| style="text-align:right" | +7% |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
* '''Supporting Metrics & Details:''' |
|||
** Gross Earned Premiums: EUR 17,416m, +10% |
|||
** All Year Combined Ratio: 97.2%, -0.1pts |
|||
** CSM release: EUR 2,954m, +EUR 215m |
|||
** Technical experience: -EUR 150m, -EUR 58m |
|||
** FY25 Average Assets: EUR 98bn |
|||
** Asset book yield: 2.5% |
|||
** FY25 Reinvestment yield¹: 3.8% |
|||
** FY24 Reserves at locked-in rate: EUR 62bn |
|||
** Liability book yield: 2.5% |
|||
** Underlying Earnings Growth vs. FY24 (at constant FX): +7% |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,799: | Line 1,862: | ||
|+ Life & Health FY25 CSM Key Sensitivities <sup>p. 43</sup> |
|+ Life & Health FY25 CSM Key Sensitivities <sup>p. 43</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Impact on CSM |
||
|- |
|- |
||
| style="text-align:left" | Baseline |
| style="text-align:left" | '''Baseline''' |
||
| style="text-align:right" | 33.3 |
| style="text-align:right" | '''33.3''' |
||
|- |
|- |
||
| style="text-align:left" | Interest rates +50bps |
| style="text-align:left" | Interest rates +50bps |
||
| Line 1,832: | Line 1,895: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Structured and Private Credit Assets (100%) <sup>p. 43</sup> |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion unless otherwise mentioned |
||
! class="col-s" style="text-align:right" | Value |
! class="col-s" style="text-align:right" | Value |
||
! class="col-s" style="text-align:right" | % of total G/A portfolio |
! class="col-s" style="text-align:right" | % of total G/A portfolio |
||
! class="col-m" style="text-align:right" | Details |
|||
|- |
|- |
||
| style="text-align:left" | Residential Mortgages |
| style="text-align:left" | Residential Mortgages |
||
| style="text-align:right" | 16 |
| style="text-align:right" | 16 |
||
| style="text-align:right" | 4% |
| style="text-align:right" | 4% |
||
| style="text-align:right" | EUR 6bn Dutch mortgages, NHG guaranteed; EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) |
|||
|- |
|- |
||
| style="text-align:left" | CLO & ABS |
| style="text-align:left" | CLO & ABS |
||
| style="text-align:right" | 25 |
| style="text-align:right" | 25 |
||
| style="text-align:right" | 6% |
| style="text-align:right" | 6% |
||
| style="text-align:right" | 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) |
|||
|- |
|- |
||
| style="text-align:left" | Infrastructure debt |
| style="text-align:left" | Infrastructure debt |
||
| style="text-align:right" | 8 |
| style="text-align:right" | 8 |
||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
| style="text-align:right" | Skewed towards resilient industries (Telecom, Utilities, Transport) |
|||
|- |
|- |
||
| style="text-align:left" | CRE debt |
| style="text-align:left" | CRE debt |
||
| style="text-align:right" | 8 |
| style="text-align:right" | 8 |
||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
| style="text-align:right" | Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV |
|||
|- |
|- |
||
| style="text-align:left" | Mid-Market lending |
| style="text-align:left" | Mid-Market lending |
||
| style="text-align:right" | 10 |
| style="text-align:right" | 10 |
||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
| style="text-align:right" | Strong diversification with EUR 8m average ticket; Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation |
|||
|- |
|- |
||
| style="text-align:left" | Other |
| style="text-align:left" | Other |
||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
| style="text-align:right" | 0% |
| style="text-align:right" | 0% |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | '''Total |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right" | 69 |
| style="text-align:right" | '''69''' |
||
| style="text-align:right" | 15% |
| style="text-align:right" | '''15%''' |
||
| style="text-align:right" | o/w 54% participating |
|||
|} |
|} |
||
</div> |
</div> |
||
* Includes scope impact <sup>p. 43</sup> |
|||
* Changes versus FY24 at constant FX <sup>p. 43</sup> |
|||
* Reinvestment yield on fixed income assets <sup>p. 43</sup> |
|||
* Incl. recapture of Laya <sup>p. 43</sup> |
|||
* EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 43</sup> |
|||
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 43</sup> |
|||
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 43</sup> |
|||
* Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 43</sup> |
|||
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 43</sup> |
|||
* Strong diversification with EUR 8m average ticket <sup>p. 43</sup> |
|||
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 43</sup> |
|||
* o/w 54% participating <sup>p. 43</sup> |
|||
* (flow) '''Technical Result''' (In Euro million, pre-tax) <sup>p. 43</sup> |
* (flow) '''Technical Result''' (In Euro million, pre-tax) <sup>p. 43</sup> |
||
* (flow) '''Financial Result''' (In Euro million, pre-tax) <sup>p. 43</sup> |
* (flow) '''Financial Result''' (In Euro million, pre-tax) <sup>p. 43</sup> |
||
* (flow) '''Underlying Earnings before tax''' <sup>p. 43</sup> |
* (flow) '''Underlying Earnings before tax''' <sup>p. 43</sup> |
||
* |
* 1. Debt and Invested Assets, p.31 <sup>p. 44</sup> |
||
* 2. Additional P&C disclosures, p.36 <sup>p. 44</sup> |
|||
* 3. Additional IFRS17 disclosures, p.41 <sup>p. 44</sup> |
|||
* 4. Sustainability, p.44 <sup>p. 44</sup> |
|||
** 4. Sustainability <sup>p. 44</sup> |
|||
=== Expanding AXA's role in society: AXA for Progress Index 1 === |
=== Expanding AXA's role in society: AXA for Progress Index 1 === |
||
| Line 1,893: | Line 1,950: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
|+ |
|+ Sustainability targets and 2025 performance <sup>p. 45</sup> |
||
! style="text-align:left" | |
! style="text-align:left" | Metric |
||
! class="col- |
! class="col-s" style="text-align:right" | Target |
||
! class="col- |
! class="col-s" style="text-align:right" | 2025 Result |
||
|- |
|- |
||
| style="text-align:left" | '''As a Global |
| style="text-align:left" | '''As a Global Investor''' |
||
| class="col- |
| class="col-s" style="text-align:right" | — |
||
| class="col- |
| class="col-s" style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Climate transition financing |
| style="text-align:left" | Climate transition financing (per year) |
||
| class="col- |
| class="col-s" style="text-align:right" | €5bn |
||
| class="col- |
| class="col-s" style="text-align:right" | €6.4bn |
||
|- |
|- |
||
| style="text-align:left" | Community resilience financing |
| style="text-align:left" | Community resilience financing (per year) |
||
| class="col- |
| class="col-s" style="text-align:right" | >€500m |
||
| class="col- |
| class="col-s" style="text-align:right" | €1.4bn |
||
|- |
|- |
||
| style="text-align:left" | '''As a Global |
| style="text-align:left" | '''As a Global Insurer''' |
||
| class="col- |
| class="col-s" style="text-align:right" | — |
||
| class="col- |
| class="col-s" style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | P&C GWP |
| style="text-align:left" | P&C GWP for transition underwriting (cumulative 2024-2026) |
||
| class="col- |
| class="col-s" style="text-align:right" | €6bn |
||
| class="col- |
| class="col-s" style="text-align:right" | €4.6bn |
||
|- |
|- |
||
| style="text-align:left" | Climate adaptation solutions & services (cumulative 2024-2026) |
| style="text-align:left" | Climate adaptation solutions & services (cumulative 2024-2026) |
||
| class="col- |
| class="col-s" style="text-align:right" | >20,000 |
||
| class="col- |
| class="col-s" style="text-align:right" | 19,698 |
||
|- |
|- |
||
| style="text-align:left" | Inclusive insurance customers |
| style="text-align:left" | Inclusive insurance customers |
||
| class="col- |
| class="col-s" style="text-align:right" | >20m by 2026 |
||
| class="col- |
| class="col-s" style="text-align:right" | 20.6m |
||
|- |
|- |
||
| style="text-align:left" | '''As a |
| style="text-align:left" | '''As a Company''' |
||
| class="col- |
| class="col-s" style="text-align:right" | — |
||
| class="col- |
| class="col-s" style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Employees trained on climate adaptation (cumulative 2024-2026) |
||
| class="col- |
| class="col-s" style="text-align:right" | >80,000 by 2026 |
||
| class="col- |
| class="col-s" style="text-align:right" | 46,420 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Net-Zero contribution (vs 2019) |
||
| class="col- |
| class="col-s" style="text-align:right" | -50% by 2030 |
||
| class="col- |
| class="col-s" style="text-align:right" | -64% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Employee volunteering |
||
| class="col- |
| class="col-s" style="text-align:right" | 50% by 2026 |
||
| class="col- |
| class="col-s" style="text-align:right" | 56% |
||
|} |
|} |
||
</div> |
</div> |
||
* '''Climate transition financing''': The scope covers corporate and sovereign debt, real estate, and private assets, with a timeframe per annum through 2030 <sup>p. 45</sup>. |
|||
* '''Community resilience financing''': The scope covers corporate and sovereign debt, real estate, and private assets, with a timeframe per annum through 2030 <sup>p. 45</sup>. |
|||
* AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026 <sup>p. 45</sup> |
|||
* '''P&C GWP for transition underwriting''': The scope includes AXA France, AXA Germany, AXA Switzerland, AXA UK & Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL <sup>p. 45</sup>. |
|||
* Scope: Corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2026 <sup>p. 45</sup> |
|||
* '''Climate adaptation solutions & services''': The target was revised in 2025 from >9,000 to >20,000 due to strong support for these services in 2024 and 2025 <sup>p. 45</sup>. |
|||
* Scope: AXA France, AXA Germany, AXA Switzerland, AXA XL, AXA Hong Kong, AXA Japan, AXA Mexico, and AXA XL. Gross Written Premiums (GWP). Timeframe: cumulative 2024-2026 <sup>p. 45</sup> |
|||
** The scope includes the commercial lines portfolio of AXA France, Germany, Switzerland, UK, Belgium, Hong Kong, Mexico, and AXA XL <sup>p. 45</sup>. |
|||
* Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL. Climate solutions & services include: (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaptation solutions & services in 2024 and 2025, AXA is proposing a significant increase in the target for the 2024-2026 period, from >9,000 to >20,000 <sup>p. 45</sup> |
|||
** Services include training/education, risk assessment/awareness, gap analysis, prevention/adaptation solutions, and/or crisis management/remediation response <sup>p. 45</sup>. |
|||
* Inclusive insurance includes underserved populations and markets and modest income segments in mature markets <sup>p. 45</sup> |
|||
* '''Inclusive insurance customers''': This covers low-income to mass market segments in emerging markets and modest income segments in mature markets <sup>p. 45</sup>. |
|||
* Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026 <sup>p. 45</sup> |
|||
* '''Employees trained on climate adaptation''': Training is completed under the AXA Sustainability Academy, with a cumulative timeframe of 2024-2026 <sup>p. 45</sup>. |
|||
* Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030 <sup>p. 45</sup> |
|||
* '''Net-Zero contribution''': |
|||
* Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage) <sup>p. 45</sup> |
|||
** The emissions scope covers energy (Scopes 1 and 2), car fleet, and business travel, with a timeframe of 2019-2030 <sup>p. 45</sup>. |
|||
* Target revised in 2025 <sup>p. 45</sup> |
|||
** Offsetting residual emissions will use carbon credits from projects that capture and store atmospheric carbon, such as restorative agriculture, forest restoration, or carbon capture and storage <sup>p. 45</sup>. |
|||
* AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026 <sup>p. 45</sup>. |
|||
=== Sustainability Performance & Ratings === |
=== Sustainability Performance & Ratings === |
||
| Line 1,958: | Line 2,017: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
|+ ESG |
|+ ESG ratings, 2025 <sup>p. 46</sup> |
||
! style="text-align:left" | Rating Agency |
! style="text-align:left" | Rating Agency |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | 2025 Score/Rating |
||
! class="col-m" style="text-align:right" | 2025 Result |
|||
|- |
|- |
||
| style="text-align:left" | S&P Global |
| style="text-align:left" | S&P Global (Dow Jones Best-in-Class Europe & World indices) |
||
| class="col-m" style="text-align:right" | |
| class="col-m" style="text-align:right" | 97th percentile |
||
| class="col-m" style="text-align:right" | 97th |
|||
|- |
|||
| style="text-align:left" | S&P Global |
|||
| class="col-m" style="text-align:right" | Score |
|||
| class="col-m" style="text-align:right" | AAA |
|||
|- |
|- |
||
| style="text-align:left" | MSCI |
| style="text-align:left" | MSCI |
||
| class="col-m" style="text-align:right" | Score |
|||
| class="col-m" style="text-align:right" | AAA |
| class="col-m" style="text-align:right" | AAA |
||
|- |
|- |
||
| style="text-align:left" | CDP |
| style="text-align:left" | CDP |
||
| class="col-m" style="text-align:right" | Score |
|||
| class="col-m" style="text-align:right" | B |
| class="col-m" style="text-align:right" | B |
||
|- |
|- |
||
| style="text-align:left" | Morningstar Sustainalytics |
| style="text-align:left" | Morningstar Sustainalytics |
||
| class="col-m" style="text-align:right" | |
| class="col-m" style="text-align:right" | 17.0, Low risk |
||
| class="col-m" style="text-align:right" | 17.0 - Low risk |
|||
|- |
|- |
||
| style="text-align:left" | FTSE Russell |
| style="text-align:left" | FTSE Russell (FTSE4Good Index Series) |
||
| class="col-m" style="text-align:right" | Score in FTSE4Good Index Series |
|||
| class="col-m" style="text-align:right" | 4.3/5 |
| class="col-m" style="text-align:right" | 4.3/5 |
||
|} |
|} |
||
</div> |
</div> |
||
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results are as of February 6th, 2026 <sup>p. 46</sup>. |
|||
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares) <sup>p. 46</sup>. |
|||
* Results as of February 6th, 2026 <sup>p. 46</sup>. |
|||
=== Scope === |
=== Scope === |
||
| Line 2,033: | Line 2,080: | ||
== Abbreviations == |
== Abbreviations == |
||
* '''AA''': Senior |
* '''AA''': Senior Secured |
||
* '''AAA''': |
* '''AAA''': Prime |
||
* '''ABS''': Asset-Backed Securities |
* '''ABS''': Asset-Backed Securities |
||
* '''AEP''': Aggregate Exceedance Probability |
* '''AEP''': Aggregate Exceedance Probability |
||
* '''AI''': Artificial Intelligence |
* '''AI''': Artificial Intelligence |
||
* '''AMF''': Autorité des |
* '''AMF''': Autorité des Marchés Financiers |
||
* '''APAC''': Asia-Pacific |
* '''APAC''': Asia-Pacific |
||
* '''AXA IM''': AXA Investment Managers |
* '''AXA IM''': AXA Investment Managers |
||
* '''AXA UK''': AXA United Kingdom |
* '''AXA UK''': AXA United Kingdom |
||
* '''AXA XL''': AXA XL (AXA's corporate and specialty risk division) |
|||
* '''AY''': Accident Year |
* '''AY''': Accident Year |
||
* '''BBA''': |
* '''BBA''': Balance-Sheet Based Accounting |
||
* '''BNP''': Banque Nationale de Paris |
|||
* '''CDP''': Carbon Disclosure Project |
* '''CDP''': Carbon Disclosure Project |
||
* '''CH''': Switzerland |
|||
* '''CLO''': Collateralized Loan Obligation |
* '''CLO''': Collateralized Loan Obligation |
||
* '''CRE''': Commercial Real Estate |
* '''CRE''': Commercial Real Estate |
||
* '''CSA''': Corporate Sustainability Assessment |
* '''CSA''': Corporate Sustainability Assessment |
||
* '''CSM''': Contractual Service Margin |
* '''CSM''': Contractual Service Margin |
||
* '''CY''': |
* '''CY''': Current Year |
||
* '''DE''': Germany |
|||
* '''DPS''': Dividend Per Share |
* '''DPS''': Dividend Per Share |
||
* '''EME''': Emerging Markets |
* '''EME''': Emerging Markets |
||
| Line 2,059: | Line 2,106: | ||
* '''ESMA''': European Securities and Markets Authority |
* '''ESMA''': European Securities and Markets Authority |
||
* '''EU''': European Union |
* '''EU''': European Union |
||
* '''EUR''': Euro |
|||
* '''FTSE''': Financial Times Stock Exchange |
* '''FTSE''': Financial Times Stock Exchange |
||
* '''FX''': Foreign Exchange |
* '''FX''': Foreign Exchange |
||
| Line 2,073: | Line 2,119: | ||
* '''JPY''': Japanese Yen |
* '''JPY''': Japanese Yen |
||
* '''LATAM''': Latin America |
* '''LATAM''': Latin America |
||
* '''LTV''': Loan- |
* '''LTV''': Loan-To-Value |
||
* '''MSCI''': Morgan Stanley Capital International |
* '''MSCI''': Morgan Stanley Capital International |
||
* '''MX''': Mexico |
* '''MX''': Mexico |
||
| Line 2,086: | Line 2,132: | ||
* '''PVEP''': Present Value of Expected Profits |
* '''PVEP''': Present Value of Expected Profits |
||
* '''PYD''': Prior Years' Reserve Development |
* '''PYD''': Prior Years' Reserve Development |
||
* '''RCG''': |
* '''RCG''': Reclassification of Capital Gains |
||
* '''ROE''': Return |
* '''ROE''': Return On Equity |
||
* '''SCR''': Solvency Capital Requirement |
* '''SCR''': Solvency Capital Requirement |
||
* '''SHE''': Shareholders' Equity |
* '''SHE''': Shareholders' Equity |
||
* '''SME''': Small and Medium-sized Enterprises |
* '''SME''': Small and Medium-sized Enterprises |
||
* '''TVOG''': Time Value of Options |
* '''TVOG''': Time Value of Options & Guarantees |
||
* '''UE''': Underlying Earnings |
|||
* '''UEPS''': Underlying Earnings Per Share |
* '''UEPS''': Underlying Earnings Per Share |
||
* '''UK''': United Kingdom |
* '''UK''': United Kingdom |
||
* '''US''': United States |
* '''US''': United States |
||
* '''USD''': United States Dollar |
|||
* '''VAT''': Value Added Tax |
* '''VAT''': Value Added Tax |
||
* '''VFA''': Variable Fee Approach |
* '''VFA''': Variable Fee Approach |
||
Revision as of 21:24, 21 June 2026
| Document info | |
|---|---|
| Organization | AXA |
| Year | 2025 |
| Period | FY |
| Period label | FY25 |
| Document type | Analyst presentation |
| Publication date | 2026-02-26 |
| Language | English |
| Pages | 49 |
| Source | Original URL |
| Archive file | .md file |
This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
Front matter
Full Year 2025 earnings presentation
- Full Year 2025 Earnings Presentation p. 1
- February 26, 2026 p. 1
Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures
- Forward-looking statements: This presentation contains statements that are predictions of or indicate future events, trends, plans, or objectives. They are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target', or conditional verbs like 'would' and 'could' p. 2.
- A specific example is the statement regarding expected underlying earnings per share (UEPS) growth for 2026, which is provided as one-off guidance for the final year of the current strategic plan p. 2.
- These statements are based on management's current views and are subject to change. They involve known and unknown risks and uncertainties, many outside of AXA's control, which could cause actual results to differ materially p. 2.
- For a description of important risk factors, refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 p. 2.
- AXA disclaims any obligation to publicly update or revise these statements, except as required by law p. 2.
- Non-GAAP financial measures: The presentation uses certain non-GAAP financial measures, or alternative performance measures (APMs), to analyze operating trends and financial performance p. 2.
- These measures may not be comparable to those used by other companies and should not be considered a substitute for IFRS financial statements p. 2.
- Examples of APMs include "Underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing", as defined by ESMA guidelines and the AMF's 2015 position statement p. 2.
- Reconciliation of these APMs to IFRS measures can be found in AXA's 2025 Activity Report, with further details in the Glossary p. 2.
- Document availability: AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com) p. 2.
- Financial statement status: The consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to the completion of an audit by statutory auditors p. 2.
- The presentation is titled "Full Year 2025 Earnings" p. 2.
Table of contents
- 1. FY25 Highlights: presented by Thomas Buberl, Group CEO, starting on p.04 p. 3.
- 2. FY25 Business Performance: presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on p.09 p. 3.
- 3. FY25 Financial Performance: presented by Alban de Mailly Nesle, Group CFO, starting on p.13 p. 3.
FY25 Highlights
- Presented by Thomas Buberl, Group CEO p. 4.
Full Year 2025 | Excellent performance
| EUR billion unless otherwise mentioned | Metric | Value / Change |
|---|---|---|
| — | Revenues | +6% vs. FY24 |
| — | Underlying EPS | +8% vs. FY24 |
| — | ROE (FY25) | 16% |
| — | Solvency II ratio (FY25) | 224% |
| — | Dividend per Share (DPS) growth | +8% |
| — | Annual share buyback | 1.25 |
- Confident to deliver underlying EPS growth at the upper end of the 6%-8% target range for 2026 p. 5
- ¹Dividend is based on the proposal by AXA's Board of Directors on February 25, 2026, and is subject to approval by the Shareholders' Annual General Meeting on April 30, 2026 p. 5
- ²Share buyback follows AXA's Board of Directors' approval on February 25, 2026, and is expected to commence as soon as reasonably practicable, subject to market conditions p. 5
Executing the plan on growth, margin and efficiency
| EUR billion | FY24 | FY25 |
|---|---|---|
| Underlying earnings | 8.1 | 8.4 |
- Underlying earnings +6% p. 6
- High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) p. 6
- Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency p. 6
- Scaling the business: Continued investments in growth and technology p. 6
- Consistent earnings growth while enhancing reserve prudence p. 6
- Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX p. 6
Diversified franchise, well positioned in an attractive industry
| Segment | Share |
|---|---|
| Life | 33% |
| Health | 17% |
| Large & Specialty | 17% |
| SME & Mid-market | 16% |
| Retail | 17% |
- Secular trends fueling demand across businesses p. 7
- Protection gaps and emerging corporate risks (relevant for SME & Mid-market and Large & Specialty segments) p. 7
- Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) p. 7
- Our right to win p. 7
- Leading brand & high customer NPS p. 7
- Strong and diversified distribution p. 7
- Technical expertise to price & underwrite risks p. 7
- Scale offering cost advantage p. 7
Laying the foundation for the next plan
- (icon) Clear tech and AI roadmap p. 8
- (icon) Driving efficiency p. 8
- (icon) Enhancing capital allocation discipline p. 8
- (icon) Building resilience p. 8
- Confidence in sustaining earnings growth p. 8
FY25 Business Performance
- Guillaume Borie p. 9
- Global Head of Finance, Strategy, Underwriting, Risk, and Technology p. 9
Strong delivery across our businesses
| EUR billion unless otherwise mentioned | % of total GWP | Gross written premiums | GWP change | Underlying earnings | UE change |
|---|---|---|---|---|---|
| France | 27% | 31 | +6% | 2.2 | +7% |
| Europe | 38% | 43 | +6% | 3.5 | +9% |
| AXA XL | 17% | 19 | +4% | 1.9 | +9% |
| Asia, Africa & EME-LATAM | 18% | 20 | +13% | 1.5 | +6% |
- A checkmark icon is displayed next to each business segment's results p. 10.
- Footnotes: Changes for Gross written premiums are at constant scope and FX; changes for underlying earnings are at constant FX. The total GWP base for FY25 excludes AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers p. 10.
P&C | Strong margins, confidence in sustaining growth
| Segment | Share |
|---|---|
| Retail | 34% |
| SME & Mid-market | 33% |
| AXA XL (Large & Specialty) | 33% |
- Underlying earnings +9% to EUR 5.9bn (FY25 vs. FY24 at constant FX) p. 11.
- AXA XL (Large & Specialty) includes AXA XL Re premiums of EUR 2.6bn p. 11.
- Strategic priorities for 2025 p. 11:
- Retail and SME & Mid-market: Growing volumes while expanding margins p. 11.
- AXA XL (Large & Specialty): Profitable growth with stable margins p. 11.
- Strategic priorities beyond 2025 p. 11:
- Retail and SME & Mid-market: Investing to improve customer retention and expanding distribution footprint p. 11.
- AXA XL (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management p. 11.
- Additional drivers supporting growth include p. 11:
- Continued progress on efficiency p. 11.
- Higher investment income p. 11.
- Data & AI to further enhance customer experience and technical excellence p. 11.
- (donut chart) GWP of EUR 58bn, with the following segment mix p. 11:
L&H | Good momentum, well positioned to capture growth opportunities
| Business type | Share |
|---|---|
| Long-term | 70% |
| Short-term | 30% |
- Underlying earnings +7% to EUR 3.5bn (change FY25 vs. FY24 at constant FX) p. 12.
- Strategic priorities for 2025:
- Long-term business: Accelerating net flows in Savings at attractive margins p. 12.
- Short-term business: Growing technical results while absorbing the Mexico VAT impact p. 12.
- Strategic priorities beyond 2025:
- Long-term business: Capturing savings & retirement opportunities and sourcing the best asset management products for customers p. 12.
- Short-term business: Capitalizing on demand for health & protection while further improving margins p. 12.
- Additional strategic initiatives:
- Focus on cost reduction p. 12.
- Increasing penetration of Protection riders in Savings offerings p. 12.
- Leveraging AI to reduce claims leakage and improve customer outcomes in Health p. 12.
- (donut) GWP of EUR 57bn, split between Long-term (70%) and Short-term (30%) business p. 12.
FY25 Financial Performance
- FY25 Financial Performance p. 13
- Alban de Mailly Nesle, Group CFO p. 13
P&C | Continued disciplined growth
| EUR billion unless otherwise mentioned | FY24 | FY25 | Change | Pricing effect | Volume effect |
|---|---|---|---|---|---|
| Commercial lines | — | 35.8 | +4% | +2% | +2% |
| AXA XL Reinsurance | — | 2.6 | +8% | +0.3% | +7% |
| Retail lines | — | 19.7 | +7% | +5% | +2% |
| Total | 56.5 | 58.0 | +5% | — | — |
- Commercial lines: Continued pricing momentum and volume growth in Mid-market and SME p. 14.
- Commercial lines: Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance p. 14.
- AXA XL Reinsurance: Growth supported by alternative capital p. 14.
- Retail lines: Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) p. 14.
- All changes are at constant scope and FX. "Pricing" refers to price effect. "Volume" includes exposure adjustments and mix & other effects p. 14.
P&C | Delivering further margin expansion while enhancing reserve prudence
| Ratio (%) | FY24 | FY25 |
|---|---|---|
| Undiscounted CY loss ratio (ex Nat Cat) | 67.4% | 67.0% |
| Expense ratio | 25.0% | 24.8% |
| Nat Cat | 3.8% | 3.4% |
| Prior year reserve development | -1.6% | -1.1% |
| Discount | -3.6% | -3.5% |
| Combined ratio | 91.0% | 90.6% |
- A better undiscounted current year loss ratio (excluding Nat Cat) was driven by: p. 15
- Margin expansion in Commercial lines SME & mid-market business and Personal lines, reflecting a favorable pricing environment p. 15.
- Stable AXA XL Insurance margins at attractive levels, reflecting disciplined cycle management p. 15.
- The expense ratio improved, reflecting the impact of efficiency measures, while the company continued to invest in growth initiatives and technology p. 15.
- Nat Cat charges were below the normalized load p. 15.
- There was a lower reliance on prior year reserve development p. 15.
- The company is taking advantage of a good year to enhance reserve prudence p. 15.
P&C | Earnings growth from higher underwriting and financial result
| EUR million | Underlying earnings |
|---|---|
| FY24 | 5,510 |
| Volume growth | +292 |
| Margin improvement | +189 |
| Investment income | +435 |
| Insurance finance expenses | -235 |
| Tax | -169 |
| Affiliates, FX & other | -150 |
| FY25 | 5,872 |
- The above two components form the "Underwriting result," which includes expenses p. 16.
- The above two components form the "Financial result" p. 16.
- Better underwriting result from strong volume growth and an improved all-year combined ratio, while enhancing reserve prudence p. 16.
- Increase in investment income reflects higher volumes and better reinvestment yields on fixed income assets p. 16.
- Higher unwind of discount of claims reserves was in line with guidance p. 16.
- An unfavorable forex impact was recorded, notably due to USD depreciation vs. EUR p. 16.
- (waterfall) Underlying earnings bridge FY24 to FY25 (in EUR million, at constant FX): EUR 5,510m → EUR 5,872m (+9%) p. 16
- All figures are in EUR billion. All changes are at constant scope and FX p. 17.
| EUR billion unless otherwise mentioned | FY24 | FY25 | Change |
|---|---|---|---|
| Protection | — | 17.3 | +11% |
| Unit-linked | — | 9.3 | +13% |
| Capital light G/A | — | 9.0 | +7% |
| Traditional G/A | — | 1.9 | -7% |
| Total | 34.5 | 37.5 | +9% |
| EUR billion unless otherwise mentioned | FY24 | FY25 | Change |
|---|---|---|---|
| Individual | — | 10.5 | +6% |
| Group | — | 8.5 | +4% |
| Total | 17.5 | 19.0 | +5% |
| EUR billion | FY24 | FY25 |
|---|---|---|
| Protection | — | +4.9 |
| Health | — | +2.7 |
| Unit-Linked | — | +1.5 |
| Capital light G/A | — | +1.2 |
| Traditional G/A | — | -5.0 |
| Total | +1.5 | +5.4 |
- FY25 Employee Benefits GWP and other revenues were EUR 12.9bn (+4% vs. FY24), including both short-term and long-term benefits p. 17.
Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting
- All figures are in EUR billion and changes are at constant scope and FX. p. 18
- PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes. p. 18
- NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits. p. 18
- NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France. p. 18
| EUR billion unless otherwise mentioned | FY24 | FY25 | Change |
|---|---|---|---|
| PVEP | 50.9 | 49.4 | -2% |
| Protection & Health | — | 31.4 | -4% |
| Unit-Linked | — | 8.5 | +18% |
| Capital-light G/A | — | 7.8 | -10% |
| Traditional G/A | — | 1.7 | -10% |
| NB CSM (pre-tax) | 2.2 | 2.2 | +3% |
| NBV (post-tax) | 2.3 | 2.2 | stable |
| NBV margin | 4.4% | 4.5% | — |
Life & Health | Growth in new business driving Normalized CSM growth
| EUR billion | CSM | Life CSM | Health CSM |
|---|---|---|---|
| FY24 | 33.6 | 25.8 | 7.7 |
| New business CSM | +2.2 | — | — |
| Underlying return on in-force | +1.3 | — | — |
| CSM release | -3.0 | — | — |
| Economic variance | +0.6 | — | — |
| Operating variance | -0.3 | — | — |
| Affiliates, FX & other | -1.4 | — | — |
| FY25 | 33.0 | 25.4 | 7.6 |
- Normalized CSM increased by +2% at constant scope and FX; CSM release growth reflects better margins, while new business CSM growth was impacted by higher rates p. 19.
- Economic variance reflects tightening government spreads and positive equity market returns p. 19.
- Operating variance was driven by better margins and net flows, which were more than offset by a reduction in the duration of Group Life business in Switzerland p. 19.
- FX impact was mainly from JPY and HKD depreciation p. 19.
Life & Health | Strong momentum in both short-term and long-term business
| EUR million unless otherwise mentioned | FY24 | FY25 |
|---|---|---|
| Short-term technical margin | 415 | 479 |
| Long-term result incl. CSM release | 2,680 | 2,804 |
| Financial result | 975 | 946 |
| Tax & others | -748 | -728 |
| Total Underlying earnings | 3,323 | 3,501 |
| EUR million | Underlying earnings |
|---|---|
| FY24 | 3,323 |
| Short-term technical margin | +60 |
| Long-term result incl. CSM release | +156 |
| Financial result | -11 |
| Tax, FX and others | -27 |
| FY25 | 3,501 |
| EUR billion | FY24 | FY25 | Change vs. FY24 |
|---|---|---|---|
| Life | 2.6 | 2.7 | +4% |
| Health | 0.7 | 0.8 | +17% |
- Strong short-term technical margin reflects underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) p. 20.
- Higher long-term results from an increase in CSM release (+8%), reflecting growth in the reserve base, including from favorable equity market performance and better margins p. 20.
- (waterfall) Underlying earnings +7% at constant FX, from EUR 3,323m in FY24 to EUR 3,501m in FY25 p. 20.
Growth in net income reflecting higher earnings & the gain from the sale of AXA IM
| EUR billion unless otherwise mentioned | FY24 | FY25 | Change |
|---|---|---|---|
| Underlying earnings | — | — | — |
| Property & Casualty | 5.5 | 5.9 | +9% |
| Life & Health | 3.3 | 3.5 | +7% |
| Asset Management | 0.4 | 0.2 | -57% |
| Holdings & other | -1.2 | -1.2 | — |
| Total underlying earnings | 8.1 | 8.4 | +6% |
| Net income reconciliation | — | — | — |
| Non-financial flows | -0.5 | +2.1 | — |
| Financial flows (incl. RCG) | +0.3 | -0.7 | — |
| Total net income | 7.9 | 9.8 | +26% |
- Of which capital gains from AXA IM disposal: FY25 EUR +2.2bn p. 21
- Commentary on underlying earnings:
- Driven by strong performance from insurance businesses p. 21.
- Stable holding cost is expected to remain at the current level in 2026 p. 21.
- Commentary on net income:
- Higher net income mainly reflects higher underlying earnings and the gain from the sale of AXA IM p. 21.
- Lower financial flows reflect unfavorable forex impact p. 21.
| Euro | FY24 | FY25 | Change |
|---|---|---|---|
| Underlying earnings per share | 3.59 | 3.86 | +8% |
- Drivers of change:
- +6% from earnings growth p. 21
- +3% from capital management p. 21
- -2% from forex, which includes -1% from temporary earnings dilution from the AXA IM sale due to the timing of the anti-dilutive share buyback p. 21
- Change for underlying earnings and net income is at constant FX; change for underlying earnings per share is on a reported basis p. 21.
| EUR billion unless otherwise mentioned | FY24 | HY25 | FY25 |
|---|---|---|---|
| Shareholders' equity (Group share) | 49.9 | 45.5 | 47.2 |
| SHE (excl. OCI) | 58.0 | 52.7 | 54.0 |
| Net OCI | -8.1 | -7.2 | -6.8 |
| SHE (excl. OCI & undated subordinated debt) | 53.2 | 47.0 | 49.4 |
| Debt gearing | 20.6% | 23.4% | 22.3% |
| Underlying ROE | 15.2% | 17.5% | 16.0% |
| EUR billion | FY24 to FY25 | HY25 to FY25 |
|---|---|---|
| Opening Shareholders' equity | 49.9 | 45.5 |
| Change in Net OCI | +1.3 | +0.4 |
| Net income for the period | +9.8 | +5.9 |
| Dividend | -4.6 | — |
| Annual share buyback | -1.2 | — |
| Anti-dilutive share buyback | -3.5 | -3.5 |
| Undated subordinated debt | -0.3 | -1.2 |
| Forex | -3.5 | -0.1 |
| Other | -0.6 | +0.3 |
| Closing Shareholders' equity | 47.2 | 47.2 |
- Footnote: Shareholders' equity is Group share p. 22.
- All figures are in EUR billion p. 22.
Higher organic cash remittance and robust cash position at Holding
| EUR billion unless otherwise mentioned | FY24 | FY25 |
|---|---|---|
| Ordinary remittance | 7.1 | 7.5 |
| Proceeds from in-force treaties | 0.6 | — |
| Total net cash remittance | 7.7 | 7.5 |
| Remittance ratio (%) | 82% | 82% |
| EUR billion | Holding cash position walk |
|---|---|
| FY24 Cash position | 4.0 |
| Net cash remittance from subsidiaries | +7.5 |
| Dividend | -4.6 |
| Annual share buyback | -1.2 |
| Anti-dilutive share buyback | -3.5 |
| Holding costs and interest expenses | -1.3 |
| Change in net debt | +1.6 |
| M&A and other | +3.1 |
| FY25 Cash position | 5.6 |
- The EUR 0.6bn proceeds are related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe.
- Remittance ratio is based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25.
- All figures in EUR billion p. 23.
Solvency II at 224%
| EUR billion unless otherwise mentioned | Solvency II ratio (pts) | Eligible Own Funds (EOF) | Solvency Capital Requirement (SCR) |
|---|---|---|---|
| FY24 | 216 | 55.9 | 25.9 |
| Regulatory & model changes | +0 | +0.2 | 0.0 |
| Normalized capital generation | +28 | +8.8 | +0.6 |
| Operating variance | -1 | -0.4 | 0.0 |
| Economic variance & FX | +4 | -2.1 | -1.2 |
| Dividend & annual share buyback | -24 | -6.0 | 0.0 |
| Management actions, debt & other | +2 | -0.1 | -0.2 |
| FY25 | 224 | 56.4 | 25.2 |
| Sensitivity | Impact (pts) |
|---|---|
| Interest rate +50bps | +2 |
| Interest rate -50bps | -1 |
| Corporate spreads +50bps | -1 |
| Euro Sovereign spreads +50bps (1) | -7 |
| Credit migration (2) | -4 |
| Listed Equity (excl. PE & Infra) +25% | -1 |
| Listed Equity (excl. PE & Infra) -25% | +2 |
| PE & Infra +25% | +14 |
| PE & Infra -25% | -19 |
| Inflation swap curve +50bps | -5 |
- Dividend & annual share buyback for EOF comprises foreseeable dividends of EUR -4.8bn and a provision for the 2026 annual share buyback of EUR -1.25bn.
- Footnote 1: Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
- Footnote 2: Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).
Solvency II -impact of the end of grandfathering period and Solvency II revision
| — | Solvency II ratio |
|---|---|
| As of 31/12/2025 | 224% |
| Impact of grandfathering period end (Jan 1, 2026) | -10 pts |
| As of 01/01/2026 | 215% |
| Impact of Solvency II revision (effective 1Q27) | +17 pts |
- The end of the grandfathering period is driven by EUR 2.4bn in grandfathered debt no longer being eligible as capital from that date.
- No change is expected in organic capital generation from the Solvency II revision.
- The revision provides additional capital flexibility.
- The impact is estimated based on the Solvency Capital Requirement (SCR) and amount of capital (EOF) under Solvency II as of January 1, 2026, as if the revision had come into force on that date.
Thomas Buberl, Group CEO conclusion
- Conclusion p. 26
- Thomas Buberl, Group CEO p. 26
Conclusion
- Record results, at the top end of the target range while enhancing reserve prudence p. 27
- All businesses in excellent shape, delivering strong growth and profitability p. 27
- Diversified franchise, well-positioned to capture future growth opportunities p. 27
- Laying foundations for the next plan and confident in delivering sustainable earnings growth p. 27
February 26, 2026 Q&A Full Year 2025 earnings
- Q&A p. 28
- Full Year 2025 Earnings p. 28
- February 26, 2026 p. 28
AXA Investor Relations | Keep in touch
| Date | Event | Location |
|---|---|---|
| March | Roadshows | Europe and US |
| May 5 | 1Q25 Activity Indicators | Paris |
| June 2 | BNP Paribas Exane CEO Conference | Paris |
| June 2-4 | Goldman Sachs European Financials Conference | Zurich |
| July 31 | HY26 Earnings Release | Paris |
| September 21 | AXA Investor Day | London |
- Contact us p. 29
- Investor Relations phone: +33 1 40 75 48 42 p. 29
- Investor Relations email: investor.relations@axa.com p. 29
- Follow us p. 29
- Website: www.axa.com p. 29
- Social media channels include YouTube, Facebook, Instagram, Twitter, and LinkedIn p. 29
- Meet our management (upcoming events) p. 29
- March: Roadshows in Europe and US p. 29
Appendices
- Appendices p. 30
- Debt and Invested Assets p. 31
- Additional P&C disclosures p. 36
- Additional IFRS17 disclosures p. 41
- Sustainability p. 44
Gross financial debt and maturity breakdown as of December 31st, 2025
All figures in EUR billion. p. 32
Gross financial debt
| EUR billion | FY24 | FY25 | Jan 1, 2026 |
|---|---|---|---|
| Senior debt | 4.8 | 4.6 | 3.2 |
| Tier 2 | 10.8 | 12.2 | 11.3 |
| Tier 1 | 3.5 | 3.5 | 5.8 |
| Total | 19.2 | 20.3 | 20.3 |
- Debt gearing: 20.6% for FY24, 22.3% for FY25 p. 32
- An annotation notes "o/w €0.4bn redeemed in Jan 2026" p. 32
Contractual maturity breakdown
| EUR billion | Total | o/w Grandfathered |
|---|---|---|
| Tier 1 | — | — |
| 2025 | 0.5 | — |
| 2028 | 0.5 | — |
| 2031-2039 | — | 0.7 |
| ≥2040 | — | 0.2 |
| Undated | — | 1.4 |
| Tier 2 | — | — |
| 2026 | 0.9 | — |
| 2030 | 0.9 | 0.7 |
| 2031-2039 | 1.5 | — |
| ≥2040 | 10.8 | 0.2 |
| Undated | 0.7 | — |
| Senior debt | — | — |
| Undated | 4.6 | — |
Economic maturity breakdown
| EUR billion | Tier 1 | Tier 2 | Senior debt | Total |
|---|---|---|---|---|
| 2025 | 0.1 | — | — | 0.1 |
| 2026 | — | 0.1 | — | 0.1 |
| 2027 | — | 2.4 | — | 2.4 |
| 2028 | 0.1 | ~0.4 | — | ~0.5 |
| 2029 | — | 2.0 | — | 2.0 |
| 2030 | ~0.2 | 0.7 | — | ~0.9 |
| 2031-2039 | 1.5 | 6.4 | -0.4 | 7.5 |
| ≥2040 | — | 0.5 | — | 0.5 |
| Undated | — | 0.7 | 4.0 | — |
| EUR billion | 2026 | 2028 | 2030 | 2031-2039 | Undated |
|---|---|---|---|---|---|
| Tier 1 | 0.1 | 0.1 | — | 0.4 | 0.8 |
| Tier 2 | — | — | 0.7 | 0.2 | — |
Footnotes
- 1. Nominal debt p. 32
- 2. In January 2026, AXA has called (i) the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF €250m perpetual callable 2010 floating issued January 2005 p. 32
- 3. Economic maturity takes into account the first date of step-up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, which has no step-up, the undated nature of the instrument is retained for this diagram. This should not be construed as an indication that the instrument will not be called for redemption when callable, as such decisions depend on capital, liquidity, and refinancing economics at the time p. 32
General Account invested assets
| EUR billion unless otherwise mentioned | Value | Share of total |
|---|---|---|
| Fixed income | 345 | 77% |
| Government bonds | 167 | 37% |
| Corporate bonds and loans | 121 | 27% |
| Other fixed income | 56 | 13% |
| Real estate | 41 | 9% |
| Private equity and hedge funds | 23 | 5% |
| Cash | 19 | 4% |
| Infrastructure equity | 10 | 2% |
| Listed equities | 10 | 2% |
| Policy loans | 2 | 0% |
| Total Insurance Invested Assets | 450 | 100% |
- FY25 Total General Account invested assets: EUR 450bn, with a duration gap of -0.4 year.
- Other fixed income (EUR 56bn) includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn).
- Listed equities figure (EUR 10bn) includes hedges; excluding hedges, the value is EUR 14bn.
- Private equity and hedge funds (EUR 23bn) includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn).
- A note indicates to refer to the financial supplement for more details.
Structured and Private Credit assets
| EUR billion unless otherwise mentioned | Value | % of G/A portfolio | Notes |
|---|---|---|---|
| CLO & ABS | 25 | 6% | 91% senior CLOs (~40% subordination); 100% AAA-A rated (92% AAA-AA). |
| Residential Mortgages | 16 | 4% | Incl. EUR 6bn NHG-guaranteed (Dutch) and EUR 10bn self-originated in CH (56% LTV) & DE (45% LTV). |
| Mid-Market lending | 10 | 2% | EUR 8m average ticket size; via SMAs with strict underwriting. |
| Infrastructure debt | 8 | 2% | Skewed towards Telecom, Utilities, and Transport. |
| CRE debt | 8 | 2% | Mainly logistics, residential, retail; mostly Europe; ~60% LTV. |
| Other | 2 | 0% | — |
| Total Structured and Private Credit Assets | 69 | 15% | 54% is participating. |
- Footnote: G/A stands for General Account.
- Skewed towards resilient industries such as Telecom, Utilities, and Transport p. 34.
- Features strong sector diversification, mainly in logistics, residential, and retail p. 34.
- Investments are made through Separately Managed Accounts (SMAs) with strict underwriting guidelines, including senior secured status, covenants, and restrictions on asset sales and sector allocation p. 34.
Investment portfolio | Fixed Income reinvestment
| Asset class | Share |
|---|---|
| Investment grade credit | 40% |
| Government bonds & related | 32% |
| ABS/CLO/IG fund financing | 21% |
| Below investment grade credit | 7% |
| Fixed income type | Yield |
|---|---|
| Public fixed income | 3.5% |
| Private & Structured fixed income | 4.7% |
| Total fixed income | 3.9% |
- Total FY25 fixed income reinvestment of EUR 57 billion, invested at an average yield of 3.9% with an average duration of 9 years p. 35.
- The reinvestment includes EUR 19.7 billion of Private & Structured Credit invested at 4.7%, which comprises CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY p. 35.
- A gradual shift is occurring from alternative total return assets to Private & Structured credit p. 35.
- ¹ Footnote: Government and Corporate bonds and related p. 35.
- ² Footnote: Private & Structured credit includes CLOs, ABS, Infra & CRE debt, Fund financing, and Private hybrid p. 35.
| Section | Title | Page |
|---|---|---|
| 1 | Debt and Invested Assets | 31 |
| 2 | Additional P&C disclosures | 36 |
| 3 | Additional IFRS17 disclosures | 41 |
| 4 | Sustainability | 44 |
- This slide presents the table of contents for the appendix or additional disclosures section. p. 36
- The slide is marked as "GIE_AXA_Confidential". p. 36
AXA XL Insurance | Large Commercial & Specialty business
| Line of business | Share |
|---|---|
| Casualty | 35% |
| Property | 29% |
| Specialty | 19% |
| Professional lines | 17% |
| Geography | Share |
|---|---|
| Americas | 46% |
| Europe & APAC | 35% |
| UK & Lloyds | 19% |
- Well diversified across lines of business and geographies p. 37
- Leading market positions across lines p. 37
- Top 3 globally in:
- Multinational Programs² p. 37
- Marine³ p. 37
- Fine Art & Specie⁴ p. 37
- Top 3 globally in:
- Managing the cycle to deliver consistent profitability p. 37
- (scatter plot) Relative positioning of business lines by Profitability (Y-axis) and Ex-price growth % (X-axis) p. 37:
- Property: Highest profitability and highest ex-price growth p. 37
- Specialty: High profitability and high ex-price growth p. 37
- Casualty: Medium profitability and medium ex-price growth p. 37
- Professional lines: Lowest profitability and lowest ex-price growth p. 37
- (scatter plot) Relative positioning of business lines by Profitability (Y-axis) and Ex-price growth % (X-axis) p. 37:
- Footnotes: 1. Including Cyber; 2. Source: McKinsey; 3. Source: Aon, Guy Carpenter, and Global Market Insights; 4. Source: Industry Research Biz (January 2026) p. 37
P&C | Focus on Reserves
- (bar chart) Claims reserves ratio (Net undiscounted claims reserves / Net earned premiums) p. 38
- IFRS4 basis: FY18 179%, FY19 185%, FY20 193%, FY21 188%, FY22 189% p. 38
- IFRS17 basis: FY22 198%, FY23 195%, FY24 180%, FY25 175% p. 38
- (bar chart) Technical reserves ratio (Net undiscounted technical reserves¹ / Net earned premiums) p. 38
- IFRS4 basis: FY18 213%, FY19 227%, FY20 233%, FY21 226%, FY22 227% p. 38
- IFRS17 basis: FY22 234%, FY23 232%, FY24 216%, FY25 210% p. 38
- ¹Includes net undiscounted claims reserves and unearned premium reserves p. 38.
P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1
| EUR million | Capacity | Retention |
|---|---|---|
| EU Windstorm | 4,000 | 600 |
| Europe Flood | 2,100 | 450 |
| Europe Earthquake | 2,100 | 400 |
| NA Hurricane | 1,200 | 600 |
| NA Earthquake | 1,200 | 600 |
| Per other perils | — | 400 |
- All figures are in Euro.
- Stable retention levels will be maintained in 2026 as in 2025.
- (diagram) Reinsurance segment (illustrative) is comprised of Alternative Capital & Cat Bonds.
- The program excludes local reinsurance covers.
- There is varying retention between Mexico (MX) and North America (NA): EUR 400m for MX and EUR 600m for NA.
- "Other perils" include Turkey earthquake, other Europe and NA perils, South America Earthquake, and a series of other secondary perils. Capacity varies by peril type.
- EU Windstorm: Capacity EUR 4.0bn, Retention EUR 600m p. 39.
- Europe Flood: Capacity EUR 2.1bn, Retention EUR 450m p. 39.
- Europe Earthquake: Capacity EUR 2.1bn, Retention EUR 400m p. 39.
- NA Hurricane: Capacity EUR 1.2bn, Retention EUR 600m p. 39.
- NA Earthquake: Capacity EUR 1.2bn, Retention EUR 600m p. 39.
P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026
Caption: Natural catastrophe charge scenarios and expectations p. 40
- Group underlying earnings deviation to average Nat Cat charges in 2026
- (net of reinsurance, post-tax)
| EUR billion unless otherwise mentioned | Deviation |
|---|---|
| More severe years (negative deviation in ca. 40% of cases) | — |
| 1/20y event (95th percentile) | -1.2 |
| 1/10y event (90th percentile) | -0.8 |
| 1/5y event (80th percentile) | -0.4 |
| Median (50th percentile) | +0.1 |
| Less severe years (positive deviation in ca. 60% of cases) | — |
| 1/5y event (20th percentile) | +0.5 |
| 1/10y event (10th percentile) | +0.7 |
| 1/20y event (5th percentile) | +0.8 |
- Average Expected Nat Cat charges
- (net of reinsurance, pre-tax)
| EUR billion unless otherwise mentioned | 2025 | 2026 |
|---|---|---|
| Average Expected Nat Cat charges | 2.6 | 2.7 |
| Estimated impact on GEP | ca. 4.5% | ca. 4.5% |
- All figures in EUR billion, net of reinsurance.
- Natural catastrophe cost is defined as the Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. The deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance).
- 1. Debt and Invested Assets, p.31 p. 41
- 2. Additional P&C disclosures, p.36 p. 41
- 3. Additional IFRS17 disclosures, p.41 p. 41
- 4. Sustainability, p.44 p. 41
P&C | Margin analysis
- (flow) The slide presents a flow diagram detailing the components of the P&C Technical and Financial results, which sum to Underlying Earnings before tax. All changes are versus FY24 at constant FX p. 42.
| EUR million | FY25 | Change vs FY24 |
|---|---|---|
| Technical Result | — | — |
| Current Accident Year Undiscounted Technical Margin | 2,778 | +707 |
| Current Accident Year Discounting | 2,009 | +115 |
| Prior Years' Reserve Development (PYD) | 622 | -341 |
| Financial Result | — | — |
| Investment Income | 3,988 | +435 |
| Insurance Finance Expenses | -1,358 | -235 |
| Underlying Earnings before tax | 8,040 | +681 |
| Tax | -2,060 | -169 |
| Affiliates, Minority interests & Other | -108 | -10 |
| Underlying Earnings | 5,872 | +501 |
- Supporting Metrics & Details:
- Gross Earned Premiums: EUR 57,656m, +6%
- Current Accident Year Undiscounted Combined Ratio: 95.2%, -1.0pt
- of which Nat Cats: 3.4%, -0.4pt
- Discounting Ratio (in Combined Ratio points): -3.5%, +0.0pt
- Current Accident Year Net Claims reserves: EUR 19.0bn
- Duration: 4.0 years
- Current Accident Year Discount rate: 2.8%
- PYD ratio: -1.1%, +0.7pt
- FY25 Average Assets: EUR 115bn
- Asset book yield: 3.5%
- FY25 Reinvestment yield on fixed income assets: 4.3%
- FY24 Reserves at locked-in rate: EUR 71bn
- Liability book yield: 1.9%
- Underlying Earnings Growth vs. FY24 (at constant FX): +9%
- 2026e Insurance Finance Expenses (pre-tax): ~-EUR 1.4bn
| Scenario | Impact |
|---|---|
| +25bps | +EUR 0.2bn |
| -25bps | -EUR 0.2bn |
- Based on a parallel shift of the full-year average yield curve used for discounting FY25 current accident year net reserve.
| Scenario | Impact |
|---|---|
| +25bps | ~-EUR 50m |
| -25bps | ~+EUR 50m |
- Sensitivity to changes in 2025 current AY Discount.
L&H | Margin analysis
- Includes scope impact p. 43
- Changes versus FY24 at constant FX p. 43
- Reinvestment yield on fixed income assets p. 43
- Incl. recapture of Laya p. 43
| EUR million unless otherwise mentioned | FY25 | Change vs FY24 |
|---|---|---|
| Technical Result | — | — |
| Short-term Technical Margin | 479 | +60 |
| Long-term Technical Margin | 2,804 | +156 |
| Financial Result | — | — |
| Investment Income (non-VFA only) | 2,484 | -1 |
| Insurance Finance Expenses (non-VFA only) | -1,538 | -9 |
| Underlying Earnings before tax | 4,229 | +205 |
| Tax | -800 | +65 |
| Affiliates, Minority interests & Other | 72 | -51 |
| Underlying Earnings | 3,501 | +219 |
- Supporting Metrics & Details:
- Gross Earned Premiums: EUR 17,416m, +10%
- All Year Combined Ratio: 97.2%, -0.1pts
- CSM release: EUR 2,954m, +EUR 215m
- Technical experience: -EUR 150m, -EUR 58m
- FY25 Average Assets: EUR 98bn
- Asset book yield: 2.5%
- FY25 Reinvestment yield¹: 3.8%
- FY24 Reserves at locked-in rate: EUR 62bn
- Liability book yield: 2.5%
- Underlying Earnings Growth vs. FY24 (at constant FX): +7%
| EUR billion | Impact on CSM |
|---|---|
| Baseline | 33.3 |
| Interest rates +50bps | -0.8 |
| Interest rates -50bps | 0.6 |
| Sovereign spreads +50bps | -1.9 |
| Sovereign spreads -50bps | 1.9 |
| Corporate spread +50bps | -0.8 |
| Corporate spread -50bps | 0.8 |
| Equities +25% | 1.8 |
| Equities -25% | -2.2 |
| EUR billion unless otherwise mentioned | Value | % of total G/A portfolio | Details |
|---|---|---|---|
| Residential Mortgages | 16 | 4% | EUR 6bn Dutch mortgages, NHG guaranteed; EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) |
| CLO & ABS | 25 | 6% | 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) |
| Infrastructure debt | 8 | 2% | Skewed towards resilient industries (Telecom, Utilities, Transport) |
| CRE debt | 8 | 2% | Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV |
| Mid-Market lending | 10 | 2% | Strong diversification with EUR 8m average ticket; Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation |
| Other | 2 | 0% | — |
| Total | 69 | 15% | o/w 54% participating |
- (flow) Technical Result (In Euro million, pre-tax) p. 43
- (flow) Financial Result (In Euro million, pre-tax) p. 43
- (flow) Underlying Earnings before tax p. 43
- 1. Debt and Invested Assets, p.31 p. 44
- 2. Additional P&C disclosures, p.36 p. 44
- 3. Additional IFRS17 disclosures, p.41 p. 44
- 4. Sustainability, p.44 p. 44
Expanding AXA's role in society: AXA for Progress Index 1
| Metric | Target | 2025 Result |
|---|---|---|
| As a Global Investor | — | — |
| Climate transition financing (per year) | €5bn | €6.4bn |
| Community resilience financing (per year) | >€500m | €1.4bn |
| As a Global Insurer | — | — |
| P&C GWP for transition underwriting (cumulative 2024-2026) | €6bn | €4.6bn |
| Climate adaptation solutions & services (cumulative 2024-2026) | >20,000 | 19,698 |
| Inclusive insurance customers | >20m by 2026 | 20.6m |
| As a Company | — | — |
| Employees trained on climate adaptation (cumulative 2024-2026) | >80,000 by 2026 | 46,420 |
| Net-Zero contribution (vs 2019) | -50% by 2030 | -64% |
| Employee volunteering | 50% by 2026 | 56% |
- Climate transition financing: The scope covers corporate and sovereign debt, real estate, and private assets, with a timeframe per annum through 2030 p. 45.
- Community resilience financing: The scope covers corporate and sovereign debt, real estate, and private assets, with a timeframe per annum through 2030 p. 45.
- P&C GWP for transition underwriting: The scope includes AXA France, AXA Germany, AXA Switzerland, AXA UK & Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL p. 45.
- Climate adaptation solutions & services: The target was revised in 2025 from >9,000 to >20,000 due to strong support for these services in 2024 and 2025 p. 45.
- The scope includes the commercial lines portfolio of AXA France, Germany, Switzerland, UK, Belgium, Hong Kong, Mexico, and AXA XL p. 45.
- Services include training/education, risk assessment/awareness, gap analysis, prevention/adaptation solutions, and/or crisis management/remediation response p. 45.
- Inclusive insurance customers: This covers low-income to mass market segments in emerging markets and modest income segments in mature markets p. 45.
- Employees trained on climate adaptation: Training is completed under the AXA Sustainability Academy, with a cumulative timeframe of 2024-2026 p. 45.
- Net-Zero contribution:
- The emissions scope covers energy (Scopes 1 and 2), car fleet, and business travel, with a timeframe of 2019-2030 p. 45.
- Offsetting residual emissions will use carbon credits from projects that capture and store atmospheric carbon, such as restorative agriculture, forest restoration, or carbon capture and storage p. 45.
- AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026 p. 45.
Sustainability Performance & Ratings
| Rating Agency | 2025 Score/Rating |
|---|---|
| S&P Global (Dow Jones Best-in-Class Europe & World indices) | 97th percentile |
| MSCI | AAA |
| CDP | B |
| Morningstar Sustainalytics | 17.0, Low risk |
| FTSE Russell (FTSE4Good Index Series) | 4.3/5 |
- The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results are as of February 6th, 2026 p. 46.
Scope
- France: includes insurance activities, banking activities and holding p. 47.
- Europe: includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities) and AXA Life Europe (insurance activities) p. 47.
- AXA XL: includes insurance and reinsurance activities and holding p. 47.
- Asia, Africa & EME-LATAM: p. 47
- Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated p. 47.
- China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income p. 47.
- Africa: Morocco (insurance activities and holding) and Nigeria (insurance activities and holding), Egypt (insurance activities and holding) which are fully consolidated p. 47.
- EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated as well as Russia (Reso) (insurance activities) which consolidated under the equity method and contributes only to the net income p. 47.
- AXA Mediterranean Holdings p. 47.
- Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings p. 47.
- AXA Investment Managers (until July 1, 2025): includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method p. 47.
- Unless otherwise specified herein, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023 p. 47.
- Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 p. 47.
Glossary
- Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% p. 48.
- Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders p. 48.
- CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period p. 48.
- Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force p. 48.
- Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow p. 48.
- Gross Written Premiums and Other Revenues (GWP & Other Revenues): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business) p. 48.
- Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) p. 48.
- New Business Value (NBV): the value of newly issued contracts during the current year p. 48. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests p. 48.
- New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided p. 48.
- New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP p. 48.
- Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes p. 48. Operating variance is net of reinsurance p. 48.
- Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term p. 48. PVEP is discounted at the reference interest rate and PVEP is Group share p. 48.
- Technical experience: consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses p. 48.
- Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance p. 48.
February 26, 2026 Thank you Full Year 2025 earnings
- Thank you p. 49.
- Full Year 2025 Earnings p. 49.
- February 26, 2026 p. 49.
Abbreviations
- AA: Senior Secured
- AAA: Prime
- ABS: Asset-Backed Securities
- AEP: Aggregate Exceedance Probability
- AI: Artificial Intelligence
- AMF: Autorité des Marchés Financiers
- APAC: Asia-Pacific
- AXA IM: AXA Investment Managers
- AXA UK: AXA United Kingdom
- AY: Accident Year
- BBA: Balance-Sheet Based Accounting
- CDP: Carbon Disclosure Project
- CH: Switzerland
- CLO: Collateralized Loan Obligation
- CRE: Commercial Real Estate
- CSA: Corporate Sustainability Assessment
- CSM: Contractual Service Margin
- CY: Current Year
- DE: Germany
- DPS: Dividend Per Share
- EME: Emerging Markets
- EOF: Eligible Own Funds
- EPS: Earnings Per Share
- ESG: Environmental, Social, and Governance
- ESMA: European Securities and Markets Authority
- EU: European Union
- FTSE: Financial Times Stock Exchange
- FX: Foreign Exchange
- GAAP: Generally Accepted Accounting Principles
- GEP: Gross Earned Premiums
- GF: Grandfathered
- GWP: Gross Written Premiums
- HKD: Hong Kong Dollar
- HY: High Yield
- IFE: Insurance Finance Expenses
- IFRS: International Financial Reporting Standards
- IG: Investment Grade
- JPY: Japanese Yen
- LATAM: Latin America
- LTV: Loan-To-Value
- MSCI: Morgan Stanley Capital International
- MX: Mexico
- NA: North America
- NB CSM: New Business Contractual Service Margin
- NBV: New Business Value
- NHG: Nationale Hypotheek Garantie
- NPS: Net Promoter Score
- OCI: Other Comprehensive Income
- PAA: Premium Allocation Approach
- PE: Private Equity
- PVEP: Present Value of Expected Profits
- PYD: Prior Years' Reserve Development
- RCG: Reclassification of Capital Gains
- ROE: Return On Equity
- SCR: Solvency Capital Requirement
- SHE: Shareholders' Equity
- SME: Small and Medium-sized Enterprises
- TVOG: Time Value of Options & Guarantees
- UE: Underlying Earnings
- UEPS: Underlying Earnings Per Share
- UK: United Kingdom
- US: United States
- VAT: Value Added Tax
- VFA: Variable Fee Approach